hg_4047.1

Basic information about the TSS

---

TSS ID: hg_4047.1 Species: human Chr: chr1		Start: 92834800 End: 92834806 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000645908.1 Distance: 50 GeneID: 6125 HGNC/MGI_ID: HGNC:10360 UniProt_ID:

Gene_name: ribosomal protein L5 Gene_symbol: RPL5 Gene_synonyms: L5 PPP1R135 uL18 Gene_source: HGNC:10360

TATA-Box annotation

---

Distance to TSS:	-2486
Nearest PromoterID:	NR_000006
Entrez ID:	6083
Nearest Unigene:
Nearest Refseq:	NR_000006
Nearest Ensembl:	ENSG00000206680
Gene Name:	ribosomal protein L5
Gene Alias:	RNU21|U21
Gene Description:	small nucleolar RNA, C/D box 21
Gene Type:	snoRNA
CpG%:	0.02
GC%:	0.41791
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RPL5 p2@RPL5 p3@RPL5 p4@RPL5 p5@RPL5
Sample		p1@RPL5	p2@RPL5	p3@RPL5	p4@RPL5	p5@RPL5
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	1007.72	143.76	9.55	58.25	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	1020.70	128.88	8.50	55.84	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	1189.64	162.04	7.52	57.87	1.74
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	975.72	126.62	4.57	44.28	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	1071.51	141.05	7.65	51.52	1.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	1192.13	151.37	5.81	48.65	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	1697.96	196.97	5.23	71.68	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	1193.66	186.75	4.84	85.02	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	927.96	130.79	7.69	69.67	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	1278.66	105.49	1.74	64.34	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	1097.90	87.31	2.83	56.19	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	1013.13	80.50	0.81	53.66	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	921.22	16.44	2.90	9.19	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	1087.33	16.69	2.10	8.27	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	822.01	17.78	2.63	5.93	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	983.83	17.10	1.51	6.29	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	1027.61	17.91	1.53	7.64	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	1009.83	19.40	2.53	5.06	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	977.27	14.40	0.53	5.33	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	1073.85	18.35	2.41	6.02	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	986.48	16.04	1.20	7.89	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	1154.85	20.71	1.73	6.56	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	1100.75	23.65	1.94	5.30	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	1026.97	18.20	1.94	8.01	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	1035.31	17.54	1.03	7.74	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	915.67	16.46	3.48	5.06	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	1122.55	20.88	1.65	10.44	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	1040.85	25.70	4.72	6.13	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	833.30	16.64	0.97	6.62	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	1072.76	21.90	1.63	8.87	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	982.24	25.12	2.72	7.54	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	910.28	16.61	1.37	7.42	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	938.24	18.78	1.06	7.39	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	1750.01	35.96	2.47	11.71	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	1196.36	23.00	2.80	8.04	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	979.58	18.97	1.15	6.71	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	1091.59	28.61	1.64	7.77	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	1044.91	25.39	2.82	6.85	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	1002.08	32.14	2.70	8.64	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	935.52	26.41	2.88	5.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	985.03	23.53	2.35	8.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	1322.82	33.38	1.61	9.81	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	1242.37	22.78	1.69	9.28	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	941.44	22.90	2.10	7.87	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	987.40	30.52	3.21	9.64	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	891.73	29.08	5.35	7.44	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	1015.04	19.43	0.96	6.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	895.04	33.38	2.68	8.05	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	885.68	18.91	0.72	7.90	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	1061.33	24.67	0.81	8.90	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	753.61	21.73	3.48	10.04	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	809.00	22.46	3.34	5.11	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	29229.67	1049.41	69.96	153.91	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	682.75	18.81	3.55	9.23	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	719.77	17.89	2.32	6.96	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	6391.02	192.12	37.75	31.88	11.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	1744.20	49.60	4.13	13.32	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	634.60	15.23	2.27	8.75	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	553.05	11.56	1.28	8.35	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	1299.13	34.89	5.34	10.69	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	628.91	19.04	1.41	5.64	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	628.64	13.46	4.49	8.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	1782.56	54.14	6.37	11.94	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	926.21	24.12	3.74	6.12	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	693.38	16.57	1.95	8.45	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	466.44	15.26	1.77	5.32	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	22322.39	646.56	80.82	80.82	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	20565.04	734.47	31.59	110.56	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	478.74	19.99	1.95	7.80	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	481.99	14.38	1.49	8.93	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	389.36	15.95	1.41	7.04	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	508.37	17.55	1.66	7.29	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	486.90	14.23	1.86	9.28	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	396.25	14.06	1.53	7.95	0.61
Adipocyte - breast, donor1	11376-118A8	801.58	47.20	0.32	6.02	0.16
Adipocyte - breast, donor2	11327-117E4	570.32	26.79	2.09	5.61	0.96
Adipocyte - omental, donor1	11473-119C6	953.82	58.27	0.25	8.14	0.00
Adipocyte - omental, donor2	11474-119C7	544.17	25.41	2.99	5.98	0.00
Adipocyte - omental, donor3	11475-119C8	751.56	34.50	1.34	4.69	0.33
Adipocyte - perirenal, donor1	11476-119C9	681.37	35.73	1.28	4.47	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	409.02	27.49	0.00	4.40	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	845.89	76.78	0.45	36.13	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	980.79	23.81	2.78	5.73	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	658.88	31.29	0.39	7.43	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	308.08	16.73	1.03	4.63	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	429.87	18.68	0.28	7.53	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	353.86	10.58	0.00	2.35	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	804.89	46.09	0.56	9.25	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	423.13	13.88	0.00	5.81	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	380.70	17.60	0.53	4.27	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	417.33	19.48	0.00	3.34	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	341.45	21.21	1.25	5.41	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	340.58	12.56	0.75	3.77	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	334.44	17.34	1.31	2.95	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	247.23	14.92	0.00	4.57	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	541.22	44.42	0.22	35.80	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	147.38	5.38	0.00	7.53	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	162.93	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	497.80	12.95	1.26	9.36	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	234.29	3.35	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	364.46	9.25	0.21	6.99	0.00
Anulus Pulposus Cell, donor1	11248-116E6	1931.97	25.17	2.40	8.35	0.11
Anulus Pulposus Cell, donor2	11463-119B5	866.48	14.94	3.67	8.82	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	781.32	41.78	6.74	13.03	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	856.99	46.45	3.04	13.46	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	755.51	25.68	8.56	12.84	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	852.53	40.06	5.38	12.55	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	1043.34	64.50	8.85	13.91	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	621.79	44.22	1.98	5.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	727.42	34.11	1.95	12.35	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	776.22	42.23	5.34	8.25	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	773.82	45.73	2.97	12.47	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	889.24	45.95	8.29	10.92	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	746.72	43.54	2.18	13.79	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	621.87	28.84	1.25	15.05	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	1387.57	68.04	0.82	14.66	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	771.11	43.67	6.82	10.92	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	681.27	37.40	1.36	9.05	0.90
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	708.85	38.04	3.75	12.32	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	749.70	38.73	2.08	10.77	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	767.91	33.14	5.88	11.49	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	613.56	30.24	4.88	4.88	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	771.74	37.15	2.82	10.78	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	614.77	32.42	2.40	10.81	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	856.72	24.78	0.00	14.16	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	745.13	34.82	3.26	11.15	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	646.02	29.36	4.19	8.39	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	809.69	38.83	5.83	14.56	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	862.87	47.05	3.42	9.11	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	678.36	39.98	7.27	8.48	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	789.50	54.72	5.70	7.98	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	750.35	32.07	3.21	9.19	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	650.13	27.36	2.84	9.81	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	721.64	42.23	4.69	12.20	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	694.55	29.90	3.22	12.86	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	629.98	27.11	2.14	12.13	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	724.75	37.44	5.85	9.36	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	776.47	35.23	2.71	12.65	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	633.20	24.95	8.32	10.69	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	901.68	62.04	9.15	14.24	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	801.25	45.59	5.09	13.24	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	644.26	29.86	3.18	10.17	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	747.85	29.78	3.88	18.12	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	729.68	29.42	2.75	11.85	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	618.24	27.55	2.90	8.41	2.03
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	719.89	43.46	6.61	13.23	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	700.99	36.45	2.20	12.38	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	623.10	48.64	2.32	9.27	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	883.06	59.15	8.45	14.79	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	703.06	35.16	3.43	9.86	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	664.84	37.30	1.20	10.83	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	856.55	45.93	8.02	10.93	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	845.04	53.56	4.14	11.49	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	729.39	43.36	28.05	7.65	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	720.74	42.97	1.78	12.46	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	819.15	44.18	3.51	8.67	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	633.11	31.52	3.67	8.87	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	917.78	48.28	7.65	10.52	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	734.85	37.25	3.77	7.32	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	767.48	30.52	0.00	4.58	4.58
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	736.12	31.02	4.43	5.54	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	663.04	30.45	3.18	12.45	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	612.77	27.99	2.91	10.54	1.09
Astrocyte - cerebellum, donor1	11500-119F6	545.80	17.44	0.12	10.19	0.00
Astrocyte - cerebellum, donor2	11580-120F5	231.07	5.13	0.17	5.31	0.00
Astrocyte - cerebellum, donor3	11661-122F5	185.63	1.68	0.21	2.31	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	1726.89	35.90	3.14	24.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	990.05	44.00	2.59	29.93	1.46
Astrocyte - cerebral cortex, donor3	11392-118C6	916.14	25.95	1.94	22.82	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	2231.78	73.74	5.05	40.03	1.49
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	2090.45	107.99	4.64	48.36	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	2039.69	107.42	3.53	43.58	1.02
Basophils, donor1	12241-129G9	794.27	8.11	0.52	0.26	0.26
Basophils, donor2	12242-129H1	1632.96	16.60	1.44	1.44	1.44
Basophils, donor3	12243-129H2	931.96	9.41	0.88	2.79	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	450.39	6.04	0.86	4.74	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	141.27	1.37	0.00	4.11	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	631.27	7.17	0.00	28.69	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	565.51	55.23	3.77	37.66	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	399.47	17.05	2.50	25.37	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	663.24	22.34	1.84	24.64	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	1026.23	18.71	6.84	23.03	1.08
Burkitt's lymphoma cell line:DAUDI	10422-106C8	4243.30	119.23	1.65	39.26	1.03
Burkitt's lymphoma cell line:RAJI	10476-106I8	4528.35	116.22	3.03	60.55	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	5346.32	49.25	2.24	16.95	2.88
CD133+ stem cells - cord blood derived, pool1	12223-129E9	7808.17	51.71	20.68	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	1195.87	6.76	0.56	2.25	0.00
CD14+ Monocytes, donor2	11305-117B9	947.12	6.12	2.04	1.30	0.74
CD14+ Monocytes, donor3	11381-118B4	720.96	6.15	1.10	1.32	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	850.83	7.08	0.28	1.42	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	802.88	7.20	0.00	3.41	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	758.73	6.25	0.66	1.64	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	790.97	8.09	0.43	0.87	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	722.98	11.16	0.60	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	577.78	9.71	0.47	1.18	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	561.62	5.52	0.67	0.50	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	568.31	8.83	0.83	0.55	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	687.75	23.06	0.74	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	547.46	7.64	0.78	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	677.12	9.44	0.18	0.53	1.25
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1325.59	21.76	1.52	1.74	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	659.30	7.02	0.70	0.47	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1016.45	11.62	1.06	1.58	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1189.23	11.09	1.11	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	776.32	7.14	1.04	0.74	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	834.91	12.97	1.00	1.40	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	1279.80	29.77	1.25	2.50	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	782.22	5.72	2.06	0.92	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	1023.12	14.48	0.45	1.13	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	637.67	14.84	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	533.94	5.92	0.81	0.27	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	864.80	10.64	0.87	1.40	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	681.73	9.68	1.68	0.84	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	727.50	7.90	1.47	0.55	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	561.16	9.51	0.00	2.11	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	574.29	13.16	0.44	0.44	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	574.91	8.72	0.87	0.87	1.05
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	717.71	9.66	2.23	0.37	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	1475.87	21.34	0.43	0.86	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	651.90	7.78	0.82	1.23	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1026.64	14.60	0.70	0.93	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	1114.49	23.66	1.86	1.39	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	1520.08	11.77	3.71	2.62	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	1564.76	12.70	1.85	1.15	1.15
CD14+CD16+ Monocytes, donor3	11912-125G4	1427.28	13.00	1.52	3.25	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	1793.76	11.21	1.40	1.71	1.09
CD14+CD16- Monocytes, donor2	11799-124C8	1626.64	11.53	1.22	1.57	1.05
CD14+CD16- Monocytes, donor3	11910-125G2	1227.67	10.70	0.45	2.90	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	1347.32	9.44	0.77	2.30	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	1338.69	8.12	3.07	2.42	2.20
CD14-CD16+ Monocytes, donor3	11911-125G3	1294.23	11.58	1.26	2.32	0.84
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4389.79	22.36	0.00	8.13	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	4348.55	22.37	3.39	5.42	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	4381.61	19.68	4.14	3.11	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	4880.50	22.92	2.13	6.40	4.26
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	5679.10	27.88	3.75	5.90	2.68
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	4304.29	22.46	2.81	5.62	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	4644.95	25.88	0.78	3.92	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	5188.77	26.37	7.91	3.95	2.64
CD19+ B Cells, donor1	11544-120B5	1533.67	11.51	3.29	2.47	0.82
CD19+ B Cells, donor2	11624-122B4	1629.31	12.33	0.73	0.73	1.45
CD19+ B Cells, donor3	11705-123B4	1481.16	11.11	2.02	1.51	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	1660.27	81.62	1.62	33.94	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	1182.89	76.70	2.00	23.97	0.00
CD34+ Progenitors, donor1	11545-120B6	2922.78	13.05	1.00	6.02	3.01
CD34+ Progenitors, donor2	11625-122B5	3972.54	26.40	2.81	7.87	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	3902.22	69.89	4.13	25.93	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	5229.86	77.12	4.06	26.16	1.13
CD4+ T Cells, donor1	11225-116C1	4501.06	26.07	1.79	7.14	1.07
CD4+ T Cells, donor2	11306-117C1	2889.74	14.70	15.92	4.29	8.57
CD4+ T Cells, donor3	11382-118B5	2258.17	14.33	5.79	2.13	2.74
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	2359.92	25.52	2.30	4.34	2.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	2318.74	22.01	1.57	3.59	1.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	1976.29	20.70	1.44	2.30	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	6504.53	26.55	5.22	4.74	2.84
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	8028.94	18.96	4.92	3.51	2.81
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	3609.36	13.18	9.89	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	1626.67	27.46	1.30	4.19	1.01
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	970.51	15.76	3.05	3.73	1.36
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	765.24	12.74	1.13	3.39	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	2883.90	19.73	4.48	2.69	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	3847.11	21.31	4.19	4.89	2.45
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	2924.56	25.08	2.20	5.28	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	2096.40	18.13	1.26	5.06	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	810.51	10.18	2.70	4.57	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	909.16	8.35	1.67	2.34	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	5898.80	17.13	5.17	4.89	3.26
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	6965.73	20.37	5.36	8.04	2.68
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	3398.16	12.55	3.59	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	2113.33	32.08	1.85	5.75	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	1375.52	22.53	1.95	4.55	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	1090.06	21.02	0.84	5.67	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	4316.85	16.68	4.55	5.56	2.53
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	4305.22	21.66	4.77	3.03	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	4004.27	26.58	4.36	7.41	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	6470.41	34.64	4.95	10.89	4.45
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	6094.87	38.77	3.69	6.46	3.69
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	5983.89	37.69	2.79	2.79	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	7241.68	32.12	2.77	8.31	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	7152.41	33.62	4.42	5.40	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	5798.12	29.26	3.08	9.24	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	5673.30	27.93	2.86	7.52	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	5758.79	30.47	1.38	5.54	4.15
CD8+ T Cells, donor1	11226-116C2	3139.07	26.52	2.29	4.58	0.98
CD8+ T Cells, donor2	11307-117C2	1629.37	21.78	7.88	1.88	3.75
CD8+ T Cells, donor3	11383-118B6	2427.43	22.22	6.31	5.81	2.52
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	688.40	50.70	4.82	19.04	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	696.88	49.13	3.12	17.01	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	919.81	51.71	4.65	14.50	1.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	1060.95	74.75	6.90	22.52	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	601.40	41.28	1.92	16.80	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	660.33	40.70	1.82	15.23	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	647.51	70.40	3.04	33.24	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	645.90	60.01	3.42	28.95	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	555.57	52.53	3.28	27.20	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	637.26	64.60	4.83	31.70	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	656.83	61.01	4.94	25.27	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	674.34	76.73	1.33	36.24	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	467.08	33.27	0.88	8.32	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	541.05	23.23	1.37	7.74	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	335.64	18.65	0.00	10.44	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	723.55	43.58	3.60	17.65	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	660.03	44.88	2.30	16.11	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	746.92	31.11	1.41	12.26	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	719.05	103.63	5.39	32.96	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	632.66	65.82	2.46	34.75	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	657.84	65.08	1.28	30.46	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	632.22	67.70	3.44	32.13	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	564.75	74.88	2.76	31.53	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	561.26	65.81	3.78	20.42	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	490.61	27.30	1.61	2.41	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	565.84	20.98	2.10	9.09	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	504.88	30.05	0.00	16.03	1.00
Cardiac Myocyte, donor1	11525-119I4	1138.68	47.52	0.00	9.14	0.00
Cardiac Myocyte, donor2	11605-120I3	928.89	33.60	3.46	19.76	0.99
Cardiac Myocyte, donor3	11686-122I3	1715.82	64.51	1.05	18.84	0.42
Chondrocyte - de diff, donor1	11261-116G1	893.01	44.37	0.00	10.05	0.00
Chondrocyte - de diff, donor2	11338-117F6	730.65	26.65	0.36	5.69	0.36
Chondrocyte - de diff, donor3	11410-118E6	931.17	22.07	1.59	5.46	0.91
Chondrocyte - re diff, donor2	11339-117F7	1176.37	63.56	0.00	8.95	0.00
Chondrocyte - re diff, donor3	11411-118E7	577.89	9.30	1.62	6.47	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	2145.06	44.18	1.95	23.75	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	1223.38	35.91	4.06	26.51	2.14
Ciliary Epithelial Cells, donor3	11399-118D4	1230.03	33.01	2.04	21.59	0.71
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	715.54	13.48	0.64	10.73	0.28
Corneal Epithelial Cells, donor1	11526-119I5	258.66	4.83	0.00	6.59	0.22
Corneal Epithelial Cells, donor2	11606-120I4	249.13	10.24	0.00	13.65	0.00
Corneal Epithelial Cells, donor3	11687-122I4	319.03	13.55	0.26	21.73	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	373.12	15.19	0.00	1.65	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	381.33	17.66	0.63	1.58	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	534.86	6.90	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	293.41	9.40	0.86	2.16	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	2168.06	19.47	1.37	2.39	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	3187.31	27.42	3.26	3.92	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	2587.65	15.49	0.48	6.78	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	780.15	44.36	0.33	20.18	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	416.02	22.30	0.59	18.78	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	533.64	27.15	0.57	12.73	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	499.74	22.02	0.00	14.15	0.00
Endothelial Cells - Artery, donor1	11264-116G4	409.55	36.36	1.45	13.38	0.00
Endothelial Cells - Artery, donor2	11341-117F9	682.31	61.64	1.18	24.94	0.71
Endothelial Cells - Artery, donor3	11413-118E9	580.62	50.31	1.40	23.84	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	1079.67	30.59	1.77	8.42	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	825.48	27.69	0.30	10.04	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	828.51	23.68	0.00	8.74	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	692.62	24.66	0.89	10.40	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	746.11	32.28	0.00	27.07	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	500.65	6.10	1.56	3.40	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	1075.92	95.23	0.40	36.01	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	345.40	19.92	1.05	7.34	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	1972.91	86.48	2.36	43.73	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	847.97	19.77	3.26	34.76	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	790.78	30.90	0.98	47.87	0.12
Endothelial Cells - Vein, donor1	11267-116G7	385.62	21.61	0.00	21.61	0.00
Endothelial Cells - Vein, donor2	11344-117G3	417.70	40.51	0.00	20.96	0.00
Endothelial Cells - Vein, donor3	11416-118F3	661.94	29.67	2.04	19.31	1.10
Eosinophils, donor1	12244-129H3	2195.56	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	414.22	19.80	0.00	1.65	0.00
Eosinophils, donor3	12246-129H5	306.75	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	258.25	4.64	0.00	6.11	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	243.38	0.00	0.00	6.24	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	406.72	0.00	0.00	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	564.46	22.58	0.82	5.75	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	415.95	37.55	1.86	8.32	1.75
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	826.29	30.66	2.82	11.70	0.98
Fibroblast - Aortic Adventitial, donor1	11245-116E3	1420.79	114.25	2.30	28.38	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	420.47	91.98	0.14	13.10	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	870.96	41.98	1.90	9.91	0.95
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	301.17	35.57	0.26	4.48	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	826.18	55.81	0.66	17.61	0.33
Fibroblast - Cardiac, donor1	11268-116G8	686.79	53.53	4.54	11.79	0.45
Fibroblast - Cardiac, donor2	11345-117G4	449.46	40.93	0.76	8.34	0.00
Fibroblast - Cardiac, donor3	11417-118F4	458.95	35.49	0.95	9.94	0.32
Fibroblast - Cardiac, donor4	11452-119A3	1372.78	62.44	0.00	14.25	0.30
Fibroblast - Cardiac, donor5	11456-119A7	1134.14	46.32	4.31	20.05	0.38
Fibroblast - Cardiac, donor6	11460-119B2	854.69	57.00	2.43	27.14	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	766.29	13.53	0.67	5.09	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	726.96	20.71	1.29	5.61	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	966.76	60.06	5.86	51.27	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	408.00	13.15	0.00	11.53	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	2854.78	17.47	2.37	2.88	1.19
Fibroblast - Dermal, donor1	11269-116G9	895.93	42.73	2.58	34.04	0.70
Fibroblast - Dermal, donor2	11346-117G5	674.50	61.79	0.94	47.17	0.00
Fibroblast - Dermal, donor3	11418-118F5	1175.25	47.27	2.42	23.09	1.09
Fibroblast - Dermal, donor4	11450-119A1	1119.38	57.77	4.97	51.89	0.23
Fibroblast - Dermal, donor5	11454-119A5	1215.94	64.90	5.06	61.58	0.87
Fibroblast - Dermal, donor6	11458-119A9	1304.10	73.74	4.55	65.62	0.49
Fibroblast - Gingival, donor1	11237-116D4	1539.86	52.89	0.42	22.28	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	656.57	26.20	0.26	9.96	0.26
Fibroblast - Gingival, donor2	11318-117D4	1152.85	43.62	5.93	27.94	1.45
Fibroblast - Gingival, donor3	11394-118C8	1305.37	22.33	1.55	10.73	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	692.94	20.78	0.00	4.16	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	483.86	13.22	0.88	4.41	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	546.73	41.78	0.31	17.93	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	687.36	37.05	0.68	14.33	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	82.57	8.47	0.00	2.47	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	549.15	24.13	0.88	15.36	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	608.82	37.91	0.14	14.04	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	787.82	45.74	0.55	28.19	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	627.16	9.68	0.44	3.82	0.00
Fibroblast - Lung, donor1	11270-116H1	375.18	19.03	0.00	9.52	0.00
Fibroblast - Lung, donor2	11347-117G6	1268.33	50.73	0.00	14.92	0.00
Fibroblast - Lung, donor3	11419-118F6	731.24	32.08	0.63	13.51	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	424.01	19.99	0.00	14.99	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	444.76	13.99	0.00	11.19	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	103.55	1.68	0.28	4.20	0.00
Fibroblast - Mammary, donor1	11540-120B1	809.10	21.11	0.00	21.92	0.41
Fibroblast - Mammary, donor2	11620-122A9	151.78	0.00	0.00	7.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	643.28	23.83	0.00	11.91	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	1819.08	70.80	0.97	36.85	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	1204.96	45.66	3.34	43.23	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	1288.21	72.82	0.31	34.58	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	448.79	19.08	0.38	12.98	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	745.44	37.26	1.89	7.02	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	375.52	10.67	0.70	4.18	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	1419.35	153.53	2.98	43.99	1.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	383.83	14.83	0.20	11.99	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	322.74	8.69	0.00	10.69	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	1099.50	23.33	1.58	22.93	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	375.86	37.31	0.00	9.33	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	1483.47	28.95	1.60	7.10	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	1585.55	56.17	1.18	14.78	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	320.41	35.20	1.20	9.33	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	1663.53	62.18	1.40	13.60	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	325.96	32.65	0.51	4.81	0.00
Fibroblast - skin normal, donor1	11553-120C5	1348.56	40.53	0.49	8.20	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	464.17	54.14	0.00	11.43	0.80
Fibroblast - skin normal, donor2	11561-120D4	1357.44	56.66	0.80	13.06	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	376.89	44.73	0.30	10.58	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	1804.63	38.94	0.91	8.95	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	2614.52	37.61	3.59	6.67	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	303.80	27.92	0.00	5.91	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	1213.28	66.47	1.60	15.87	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	1066.23	70.34	0.67	18.39	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	1667.78	46.10	5.96	11.76	1.88
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	29649.81	2548.38	66.48	398.88	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	770.43	24.40	2.61	9.59	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	837.66	60.68	0.52	14.91	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	932.44	65.58	0.00	20.04	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	641.85	56.98	0.26	20.95	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	1191.20	65.84	5.36	91.87	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	1791.71	118.68	5.10	105.92	5.10
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	2394.22	139.49	9.98	132.36	3.42
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	1833.79	22.06	7.17	34.47	4.41
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	1018.11	23.97	4.34	25.57	2.05
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	1355.61	57.06	5.35	75.29	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	1791.40	21.15	8.19	37.54	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	837.87	15.33	3.26	14.35	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	1959.49	98.17	9.29	104.36	3.54
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	1366.30	65.29	2.97	58.93	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	1127.00	36.57	3.32	37.56	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	1125.81	51.58	2.42	58.29	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	1094.72	33.70	2.35	33.82	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	1157.11	37.65	4.15	51.22	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	1164.93	37.81	3.25	54.89	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	1098.91	18.94	0.91	23.05	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	1028.91	26.28	3.36	29.02	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	952.56	19.02	0.87	29.94	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	1582.88	23.64	2.36	21.87	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	1095.54	26.39	4.29	21.94	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	1032.65	18.99	1.34	25.02	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	1347.92	21.37	3.02	18.35	1.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	1192.92	36.13	6.45	23.24	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	1946.97	59.32	0.80	25.98	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	2779.44	28.62	0.10	20.08	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	2365.42	34.50	0.17	20.83	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	1385.61	26.67	2.66	15.16	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	2059.27	46.59	0.58	24.04	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	1775.15	52.88	0.41	28.38	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	1686.34	20.42	2.89	13.20	2.06
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	1325.87	20.06	2.31	12.45	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	1094.81	27.35	2.67	16.68	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	1363.58	14.55	0.44	12.12	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	1648.59	23.98	4.18	13.16	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	985.85	25.45	2.27	15.72	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	1673.49	12.83	3.85	14.75	1.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	996.53	21.04	2.56	10.61	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	1035.90	22.14	1.27	14.08	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	1084.07	19.16	2.74	13.38	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	956.32	24.98	2.09	11.39	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	1025.10	15.37	3.07	13.61	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	1059.91	14.31	3.09	10.94	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	451.08	22.96	0.28	8.06	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	610.75	35.83	1.87	11.50	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	539.50	29.38	0.61	13.16	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	579.16	35.23	2.07	14.64	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	759.82	17.62	0.81	10.30	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	842.12	21.94	0.55	8.66	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	811.90	17.33	1.10	6.58	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	763.64	7.93	0.00	6.94	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	801.89	20.45	1.19	6.86	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	735.40	16.14	0.81	6.66	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	1374.50	11.18	0.00	5.85	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	2924.79	122.02	2.59	91.97	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	1348.78	54.39	5.24	61.01	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	1735.89	78.36	4.09	71.60	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	1449.18	110.78	1.88	43.50	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	1595.03	126.58	2.54	57.64	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	1042.78	72.87	2.77	66.41	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	1180.48	150.96	9.90	39.60	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	1348.42	122.23	5.03	61.12	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	937.01	112.31	0.00	46.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	978.96	85.20	6.96	48.69	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	1228.03	81.37	7.16	46.22	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	1516.67	117.36	11.94	47.77	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	933.03	49.98	13.33	33.32	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	1272.68	67.12	7.27	31.88	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	1287.44	70.60	3.27	40.20	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	1036.80	47.81	21.81	27.68	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	1513.07	55.98	5.09	35.94	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	1395.67	65.55	5.09	31.93	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	1515.99	75.17	8.35	35.50	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	2078.33	46.39	8.02	40.66	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	1149.30	42.33	6.51	25.16	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	1290.94	88.10	23.72	28.80	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	1656.00	84.91	8.28	34.38	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	1491.01	67.66	5.06	31.30	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	1006.28	63.22	5.27	26.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	1300.85	49.97	6.54	21.14	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	1349.19	44.33	6.19	22.82	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	1296.21	40.13	9.36	27.42	3.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	2520.04	36.22	11.56	31.59	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	1686.37	71.21	4.11	33.21	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	1356.69	34.79	12.42	27.33	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	2143.62	20.76	10.38	33.50	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	2049.46	30.17	10.26	30.17	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	2016.90	35.10	9.16	37.64	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	2328.82	30.71	12.76	36.29	1.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	2472.70	29.60	10.85	29.60	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	2200.34	35.41	17.71	37.77	8.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	2110.32	26.84	13.42	26.26	2.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	2339.68	25.89	13.17	29.84	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	1554.67	20.34	11.87	17.80	7.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	1100.11	30.44	7.16	22.68	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	1561.53	51.44	8.25	25.72	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	262.50	23.97	0.00	10.27	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	403.76	16.22	1.25	4.99	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	387.94	22.49	0.00	10.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	1237.25	21.88	5.71	10.47	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	915.27	20.47	4.18	10.86	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	856.62	90.05	2.44	26.46	0.93
Hep-2 cells mock treated, biol_rep2	11899-125E9	738.51	95.37	2.53	27.68	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	711.63	94.87	2.28	33.67	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	839.71	96.19	3.39	24.49	1.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	764.01	91.12	1.93	31.16	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	727.44	86.33	1.94	29.71	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	845.36	77.96	1.87	23.41	1.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	695.81	80.11	1.37	22.99	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	735.25	74.97	0.96	25.63	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	330.74	4.48	0.56	5.04	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	134.17	0.87	0.00	3.90	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	380.71	60.81	5.29	23.79	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	420.80	13.05	0.71	10.58	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	250.65	7.99	0.73	6.54	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	732.57	77.80	3.85	38.46	0.70
Hepatocyte, donor1	11523-119I2	391.02	24.21	2.42	6.05	0.00
Hepatocyte, donor2	11603-120I1	448.17	45.25	3.23	6.46	0.00
Hepatocyte, donor3	11684-122I1	444.20	31.90	1.23	9.20	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1298.19	75.06	8.48	30.68	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	1155.13	44.39	1.92	12.06	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	1278.90	66.13	1.10	32.24	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	238.79	12.74	0.00	25.47	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	246.99	6.68	6.68	46.73	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	243.75	0.00	0.00	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	279.64	16.61	0.00	35.99	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	245.26	22.52	2.50	30.03	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	189.89	35.60	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	251.16	23.07	0.00	20.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	223.97	27.42	0.00	18.28	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	295.63	32.49	1.62	45.48	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	350.13	11.67	0.00	20.01	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	228.73	10.89	0.00	50.83	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	320.28	34.41	1.32	26.47	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	399.11	31.04	2.22	48.78	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	424.30	26.19	0.00	31.43	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	435.24	40.31	2.52	31.49	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	303.14	27.84	0.00	57.23	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	365.87	14.63	0.00	29.27	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	347.57	19.38	1.29	31.01	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	209.29	22.54	1.61	27.37	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	227.02	0.00	0.00	23.90	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	411.51	30.97	3.26	30.97	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	423.59	28.97	0.00	27.71	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	402.43	14.37	0.00	71.86	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	392.20	41.79	0.00	39.38	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	337.92	26.78	0.00	27.70	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	30.16	0.00	45.24	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	423.42	34.93	2.83	36.35	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	370.96	46.26	4.53	42.63	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	265.36	14.74	0.00	58.97	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	357.27	39.82	0.00	36.59	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	262.99	35.57	0.00	43.20	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	147.87	0.00	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	316.93	31.25	1.28	32.52	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	255.17	27.34	0.00	30.99	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	331.89	15.80	0.00	31.61	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	331.33	27.13	0.71	24.28	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	282.06	9.95	0.00	29.86	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	125.09	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	511.14	34.57	1.85	38.89	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	298.52	28.10	0.00	36.88	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	298.60	22.00	0.00	22.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	256.60	13.21	0.00	21.56	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	256.72	19.92	0.00	37.62	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	363.11	25.94	0.00	38.90	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	263.32	18.31	0.87	16.57	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	281.22	22.50	0.00	36.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	282.25	31.36	0.00	41.81	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	357.37	20.27	1.07	14.93	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	246.61	16.63	0.00	24.94	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	236.52	11.40	0.00	34.20	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	251.28	21.17	5.52	19.33	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	332.79	9.08	0.00	18.15	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	273.18	6.21	0.00	37.25	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	273.86	10.57	0.00	7.40	0.00
Keratinocyte - epidermal, donor1	11272-116H3	800.65	56.96	0.16	23.75	0.16
Keratinocyte - epidermal, donor2	11349-117G8	481.98	35.72	1.17	23.43	0.00
Keratinocyte - epidermal, donor3	11421-118F8	982.15	58.21	1.99	42.50	0.95
Keratinocyte - oral, donor1	11251-116E9	3122.07	52.67	1.36	49.61	0.45
Keratocytes, donor1	11527-119I6	388.87	14.44	0.00	9.97	0.00
Keratocytes, donor2	11607-120I5	179.29	10.55	0.00	9.37	0.00
Keratocytes, donor3	11688-122I5	769.64	15.41	1.58	13.04	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	90.11	6.59	0.00	8.79	0.00
Lens Epithelial Cells, donor1	11529-119I8	828.48	67.96	5.39	35.60	2.16
Lens Epithelial Cells, donor2	11609-120I7	2131.91	18.22	1.27	11.99	0.69
Lens Epithelial Cells, donor3	11690-122I7	855.11	49.95	0.40	10.90	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	1023.44	36.17	0.83	12.33	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	661.41	20.65	2.23	10.60	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	787.22	38.72	3.78	9.29	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	615.68	26.89	1.61	10.75	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	514.98	12.92	0.63	9.77	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	668.66	23.93	2.59	7.12	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	589.32	21.75	0.41	10.67	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	475.05	11.38	1.26	7.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	630.98	18.58	1.83	7.04	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	679.13	32.83	1.19	11.07	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	830.60	23.46	1.94	7.37	1.16
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	427.88	10.18	1.30	5.18	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	694.06	27.53	2.79	9.06	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	713.66	22.90	0.95	9.78	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	609.00	19.64	3.02	6.04	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	705.84	22.48	2.16	9.85	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	505.65	14.03	2.18	6.86	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	572.76	19.95	1.46	7.14	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	588.78	30.94	2.63	8.23	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	562.90	14.94	1.46	8.49	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	467.49	14.44	1.74	6.72	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	666.34	36.37	1.94	14.55	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	806.54	35.82	1.08	14.00	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	741.30	29.06	1.67	9.69	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	682.75	23.85	2.07	14.00	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	776.84	29.94	0.84	12.56	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	616.68	24.06	2.86	6.62	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	680.31	35.77	3.44	6.88	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	732.84	26.53	1.13	9.03	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	611.90	18.87	1.48	7.32	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	602.33	32.47	0.97	9.21	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	682.75	27.46	2.32	6.62	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	595.05	16.60	3.72	5.08	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	660.82	35.91	1.85	12.96	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	701.96	29.90	1.48	7.41	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	571.29	17.32	2.47	6.32	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	684.77	34.09	1.61	10.94	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	761.74	34.08	1.52	11.87	1.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	813.20	28.27	1.82	7.14	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	694.41	31.29	1.42	8.53	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	630.69	19.88	3.39	9.70	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	420.76	9.34	1.24	4.98	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	676.82	34.02	1.07	7.52	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	632.12	25.81	0.65	10.78	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	404.46	12.01	2.59	4.00	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	1005.11	44.18	1.11	11.01	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	477.17	16.90	0.77	7.17	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	566.58	21.78	1.79	9.25	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	509.85	22.66	2.27	6.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	345.98	6.14	2.30	3.84	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	297.63	8.16	0.00	6.68	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	334.69	10.58	0.42	2.54	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	339.00	9.14	1.41	3.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	298.87	12.14	1.87	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	331.32	9.79	2.58	4.64	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	298.55	7.14	0.00	3.57	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	574.53	15.15	0.45	1.36	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	532.21	17.16	3.49	4.07	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	494.29	14.86	0.45	3.15	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	625.67	16.12	0.68	5.83	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	320.95	9.76	2.05	3.08	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	404.02	11.29	1.06	5.65	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	404.45	11.33	0.67	4.66	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	398.34	13.75	2.55	5.09	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	500.53	19.21	0.53	5.60	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	482.94	18.14	3.97	4.72	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	365.07	14.73	1.84	6.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	381.62	13.05	0.82	6.52	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	488.96	13.12	2.29	6.66	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	547.91	21.02	4.20	4.76	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	338.98	9.27	2.06	3.09	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	454.62	18.00	2.61	6.39	1.74
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	504.29	16.14	2.09	5.08	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	393.37	16.60	3.32	3.32	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	380.71	11.67	1.41	5.30	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	447.70	13.64	1.84	5.53	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	376.47	9.21	1.15	10.36	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	354.59	9.98	1.92	3.07	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	374.21	11.89	4.53	2.26	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	374.13	23.79	0.00	7.38	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	332.59	12.65	1.81	3.62	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	422.27	15.08	2.15	5.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	389.88	13.44	0.75	4.48	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	404.29	11.89	2.60	5.20	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	410.50	14.65	2.15	7.32	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	409.31	16.27	0.00	6.85	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	386.15	10.00	2.67	4.66	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	372.24	7.24	2.41	5.43	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	318.53	3.55	0.00	4.27	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	334.09	9.97	2.75	3.09	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	391.83	18.25	2.68	4.29	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	343.41	10.10	0.67	10.10	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	393.74	8.15	2.22	5.19	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	615.19	15.12	0.00	6.98	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	229.53	10.58	2.12	3.17	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	364.14	10.00	2.00	3.20	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	281.30	7.27	0.00	2.91	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	306.61	8.43	1.53	4.60	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	361.08	11.84	2.47	2.96	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	270.05	10.35	0.94	4.70	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	306.22	8.55	3.02	5.03	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	330.76	13.07	0.90	1.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	292.59	13.77	3.44	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	338.02	16.03	1.78	3.56	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	329.63	8.21	2.35	5.87	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	323.27	9.90	1.32	2.64	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	332.63	8.82	1.56	5.19	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	366.24	10.06	2.63	3.94	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	405.35	12.86	2.24	5.03	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	262.78	11.92	1.77	2.65	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	421.59	15.04	2.31	5.40	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	404.58	11.14	1.01	3.54	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	291.74	13.46	0.48	7.21	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	376.87	16.70	1.59	5.17	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	367.00	12.76	0.00	3.04	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	366.60	11.76	0.00	2.08	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	373.91	13.68	3.42	6.84	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	420.36	23.24	3.61	5.16	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	353.72	11.49	3.02	2.42	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	403.10	15.21	2.22	6.02	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	328.92	9.60	0.53	4.80	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	388.48	11.49	3.45	3.45	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	349.16	14.40	3.60	4.63	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	374.90	11.32	1.41	5.66	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	363.76	17.02	1.13	7.38	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	358.61	13.73	1.25	6.66	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	388.39	14.09	5.48	6.26	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	433.83	11.27	3.76	4.18	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	347.08	11.15	0.93	3.72	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	366.64	12.04	0.67	4.68	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	421.83	10.69	2.14	4.28	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	381.87	20.20	2.83	4.85	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	301.94	11.93	0.92	3.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	410.77	13.34	0.89	4.45	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	340.21	13.68	0.00	3.42	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	327.47	16.10	0.00	3.07	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	445.40	25.17	1.09	6.02	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	300.23	14.25	0.45	4.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	600.50	27.56	0.26	3.64	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	425.05	19.89	0.66	5.97	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	324.26	22.86	0.00	10.39	0.00
Macrophage - monocyte derived, donor1	11232-116C8	393.38	6.61	0.23	2.96	0.68
Macrophage - monocyte derived, donor2	11313-117C8	316.92	15.78	0.00	6.06	0.00
Macrophage - monocyte derived, donor3	11389-118C3	280.78	8.65	0.79	5.11	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	1073.19	118.95	0.00	28.14	0.53
Mallassez-derived cells, donor2	11929-125I3	741.87	74.79	0.95	17.43	0.00
Mallassez-derived cells, donor3	11930-125I4	1307.87	117.03	1.25	52.95	0.28
Mammary Epithelial Cell, donor1	11273-116H4	1585.63	100.44	1.59	24.81	0.60
Mammary Epithelial Cell, donor2	11350-117G9	1327.59	108.29	1.45	41.98	1.16
Mammary Epithelial Cell, donor3	11422-118F9	427.77	27.44	0.00	14.97	0.00
Mast cell - stimulated, donor1	11487-119E2	2845.98	87.45	0.68	8.81	0.68
Mast cell, donor1	11563-120D6	1055.24	21.84	0.32	3.78	0.22
Mast cell, donor2	11565-120D8	1343.52	16.05	0.00	3.57	0.00
Mast cell, donor3	11566-120D9	1445.30	18.24	0.90	6.53	0.90
Mast cell, donor4	11567-120E1	1290.84	12.06	0.18	4.43	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	789.67	30.16	0.67	7.87	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	1155.11	40.27	0.58	6.42	0.00
Mast cell, expanded, donor5	11939-126A4	771.16	19.96	0.92	5.05	0.57
Mast cell, expanded, donor8	11941-126A6	889.22	12.39	0.50	3.85	0.67
Melanocyte - dark, donor1	11502-119F8	1645.89	43.38	0.80	15.22	0.60
Melanocyte - dark, donor2	11582-120F7	918.85	34.26	3.46	19.38	0.35
Melanocyte - dark, donor3	11663-122F7	725.13	47.23	0.43	14.63	0.14
Melanocyte - light, donor1	11274-116H5	252.23	9.64	0.00	2.82	0.00
Melanocyte - light, donor2	11351-117H1	163.79	12.28	0.00	3.41	0.00
Melanocyte - light, donor3	11423-118G1	198.59	7.81	0.87	4.34	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	489.60	43.21	1.04	14.99	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	589.79	32.81	0.54	9.95	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	575.62	23.30	0.27	3.21	1.07
Meningeal Cells, donor1	11493-119E8	920.65	35.73	0.12	24.32	0.12
Meningeal Cells, donor2	11573-120E7	899.22	29.93	0.88	18.05	0.44
Meningeal Cells, donor3	11654-122E7	1656.36	108.89	1.14	51.35	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	1540.70	54.46	1.43	33.08	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	1371.72	60.98	0.10	8.35	0.60
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	216.84	2.63	0.00	3.94	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	167.44	2.62	0.00	13.08	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	640.82	62.43	1.44	50.23	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	967.78	34.73	0.21	8.68	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	633.33	33.17	0.00	7.04	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	305.24	16.04	0.44	16.26	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	227.94	16.07	1.46	17.53	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	196.42	10.64	0.61	11.25	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	2092.15	29.09	1.52	15.37	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	299.61	8.92	0.74	3.35	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	2482.68	34.74	1.45	14.47	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	662.92	5.64	0.89	0.59	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	441.42	16.35	4.67	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	360.55	11.53	0.00	16.65	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	1542.19	130.44	1.06	71.95	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	2262.56	36.28	2.50	15.64	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	836.72	73.29	5.08	92.89	2.90
Mesothelial Cells, donor1	11247-116E5	736.92	60.73	0.27	10.87	0.27
Mesothelial Cells, donor2	12156-128G5	746.70	67.06	1.50	10.01	0.00
Mesothelial Cells, donor3	11402-118D7	519.00	31.72	1.08	6.87	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	48.61	2.70	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	278.04	7.88	0.74	3.94	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	201.41	5.01	0.00	2.36	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	211.07	5.89	0.31	1.86	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	234.19	10.58	0.21	3.11	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	2.32	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	267.78	6.51	1.00	2.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	158.26	3.72	0.00	2.79	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	283.89	6.50	0.20	4.06	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	190.06	3.96	0.40	3.56	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	247.78	7.96	0.00	1.77	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	301.29	16.34	0.76	3.42	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	21.05	0.00	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	322.79	9.97	0.42	2.12	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	41.44	0.92	0.00	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	185.99	5.37	0.60	2.68	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	63.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	316.14	9.79	0.75	2.76	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	172.07	10.70	0.71	1.66	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	53.63	2.21	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	241.76	14.74	0.00	2.76	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	202.56	8.20	0.00	2.10	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	193.43	7.34	0.20	1.83	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	294.99	10.08	0.64	2.57	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	135.82	5.11	0.00	2.45	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	164.26	8.54	0.22	3.72	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	80.10	3.55	0.00	2.03	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	16.57	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	120.40	8.70	0.27	2.45	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	143.51	7.94	0.00	4.12	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	28.35	1.09	0.00	3.27	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	177.81	14.90	0.48	2.40	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	170.50	14.01	1.20	4.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	37.02	1.37	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	179.21	9.01	1.00	2.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	40.77	0.00	0.00	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	147.14	17.08	0.00	3.94	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	15.45	0.00	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	37.14	1.92	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	183.46	21.32	0.00	4.96	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	32.71	1.39	0.00	2.09	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	39.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	150.77	16.07	0.00	3.08	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	28.88	2.19	0.00	3.50	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	36.93	3.55	0.00	1.42	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	178.99	17.11	0.84	3.65	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	45.72	2.91	0.00	2.49	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	36.71	0.58	0.00	1.75	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	108.30	8.75	0.60	3.32	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	87.23	7.93	0.00	3.76	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	51.72	3.69	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	88.21	8.54	0.00	2.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	83.88	5.53	0.28	1.38	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	123.61	11.14	0.00	4.15	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	74.21	6.86	0.00	3.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	23.50	1.27	0.00	1.91	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	50.98	3.74	0.00	3.20	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	85.01	6.59	0.60	2.99	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	44.64	4.10	0.14	1.55	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	118.49	11.78	0.00	1.27	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	92.65	8.40	0.44	2.87	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	69.01	1.90	0.00	2.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	129.27	11.93	0.28	2.27	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	120.94	9.09	0.49	1.97	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	58.65	0.00	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	75.57	2.94	0.00	1.76	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	99.18	5.48	0.00	2.31	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	139.30	6.59	0.00	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	67.30	3.28	0.00	1.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	297.58	11.30	0.00	0.00	7.53
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	356.45	7.13	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	317.73	9.20	1.31	2.30	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	259.83	10.52	0.00	4.21	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	396.16	5.34	0.59	0.99	0.99
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	271.01	4.66	0.93	3.73	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	387.55	6.76	0.38	4.13	1.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	238.91	8.52	1.07	2.13	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	485.77	11.65	0.68	3.85	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	278.48	4.42	2.21	1.47	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	258.33	7.33	1.10	2.93	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	272.23	9.33	4.67	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	732.18	21.91	1.07	3.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	355.48	7.73	3.86	0.00	7.73
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	236.33	4.04	1.01	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	275.33	12.65	0.42	4.22	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	665.99	12.26	0.00	2.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1064.96	14.62	0.64	1.91	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	729.66	12.96	0.00	2.43	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	302.09	4.53	0.00	1.51	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	222.70	5.71	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	535.04	16.31	0.00	6.52	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	209.11	23.76	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	25.10	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	894.06	87.25	0.65	15.51	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	807.44	16.72	0.52	6.27	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	230.28	13.35	0.00	14.68	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	104.76	5.84	0.00	7.51	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	623.66	28.52	0.57	21.49	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	636.75	17.55	0.00	39.90	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	127.15	6.12	0.00	8.16	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	3087.24	167.23	5.51	56.97	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	215.13	4.19	1.67	2.93	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	231.04	13.95	0.23	14.41	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	420.47	4.59	0.81	4.86	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	331.54	7.36	0.00	7.99	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	10377.56	378.58	0.00	100.21	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	334.54	14.89	0.50	7.94	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	494.24	9.47	0.54	1.62	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	376.52	7.48	0.91	4.99	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	249.85	5.39	0.33	5.88	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	502.48	12.94	1.82	4.74	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	367.06	7.43	1.06	3.18	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	262.93	5.40	0.00	2.40	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	1230.01	21.66	0.66	8.53	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	226.37	3.09	0.33	3.58	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	472.17	14.46	0.88	7.23	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	342.47	5.63	0.70	2.11	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	310.30	0.92	0.92	5.52	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	444.74	6.43	1.29	6.43	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	1506.13	33.45	2.76	7.93	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	4654.87	98.61	10.11	35.40	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	294.08	10.92	0.45	8.47	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	283.67	7.62	0.42	3.39	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	480.16	4.98	0.47	3.56	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	348.55	8.16	0.43	3.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	14254.83	352.08	9.03	36.11	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	394.53	1.67	0.00	5.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	166.37	8.12	0.00	2.71	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	288.47	11.51	0.40	7.94	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	454.11	7.43	1.86	6.50	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	422.26	5.68	0.38	4.54	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	228.12	8.47	0.00	4.89	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	272.37	1.74	0.44	3.49	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	376.75	10.85	0.00	4.52	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	268.10	4.41	0.00	7.06	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	322.45	5.98	0.00	2.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	407.75	3.97	2.48	3.97	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	192.94	4.21	0.00	4.21	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	459.42	9.98	0.30	4.23	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	375.30	13.26	1.11	4.86	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	269.71	9.49	0.00	10.16	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	4956.25	102.19	5.11	15.33	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	342.64	4.88	1.83	4.88	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	164.92	3.15	0.31	1.89	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	302.35	1.51	0.00	4.54	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	316.46	3.96	1.58	3.16	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	1454.47	36.28	2.27	14.74	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	6671.36	222.55	10.12	25.29	5.06
Myoblast, donor1	11241-116D8	608.35	76.77	0.87	15.65	0.50
Myoblast, donor2	11322-117D8	777.32	39.70	3.26	11.51	0.58
Myoblast, donor3	11398-118D3	813.74	65.42	0.00	18.83	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	1261.59	41.44	1.90	6.71	1.17
Natural Killer Cells, donor1	11230-116C6	2343.59	23.68	0.92	4.61	0.62
Natural Killer Cells, donor2	11311-117C6	1531.30	14.17	5.73	4.82	3.02
Natural Killer Cells, donor3	11387-118C1	1455.50	15.09	3.31	3.13	1.10
Neural stem cells, donor1	11275-116H6	1462.28	54.08	0.00	16.33	0.00
Neural stem cells, donor2	11352-117H2	1299.81	34.66	0.00	21.18	0.00
Neurons, donor1	11494-119E9	983.14	47.79	5.69	38.69	1.14
Neurons, donor2	11574-120E8	1110.28	45.57	1.10	19.37	1.32
Neurons, donor3	11655-122E8	1074.57	50.15	4.11	34.53	3.29
Neutrophils, donor1	11233-116C9	67.74	0.93	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	34.79	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	103.84	2.44	0.00	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	2315.46	19.47	2.37	8.43	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	709.49	8.14	1.63	5.54	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	1244.03	27.48	3.61	10.43	0.20
Olfactory epithelial cells, donor1	11933-125I7	719.92	16.24	3.30	6.19	0.55
Olfactory epithelial cells, donor2	11934-125I8	904.37	32.28	7.67	12.45	3.62
Olfactory epithelial cells, donor3	11935-125I9	765.48	18.50	2.50	6.02	0.79
Olfactory epithelial cells, donor4	11936-126A1	742.65	16.07	1.07	6.92	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	1361.32	81.25	0.00	36.71	0.00
Osteoblast - differentiated, donor1	11276-116H7	1107.50	19.14	0.00	8.51	0.00
Osteoblast - differentiated, donor2	11353-117H3	442.38	6.86	1.14	6.86	0.00
Osteoblast - differentiated, donor3	11425-118G3	760.37	11.17	1.24	2.48	0.00
Osteoblast, donor1	11277-116H8	1051.84	30.10	0.39	19.35	0.20
Osteoblast, donor2	11354-117H4	1048.56	97.62	0.00	34.41	1.40
Osteoblast, donor3	11426-118G4	614.95	21.86	1.07	14.75	0.53
Pancreatic stromal cells, donor1	11249-116E7	1487.26	60.23	1.43	15.92	0.17
Pericytes, donor1	11491-119E6	246.68	2.11	0.00	1.67	0.00
Pericytes, donor2	11571-120E5	190.60	1.36	0.68	1.81	0.23
Pericytes, donor3	11652-122E5	390.01	13.22	0.81	11.60	0.41
Perineurial Cells, donor1	11499-119F5	1442.49	51.42	1.58	24.98	0.34
Perineurial Cells, donor2	11579-120F4	1831.48	62.29	1.38	23.28	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	2800.76	16.26	0.64	4.78	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	1254.92	10.77	6.12	3.43	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	1205.12	11.78	1.42	2.85	1.04
Placental Epithelial Cells, donor1	11278-116H9	326.22	38.03	0.00	5.50	0.24
Placental Epithelial Cells, donor2	11355-117H5	596.58	25.50	0.00	5.54	1.11
Placental Epithelial Cells, donor3	11427-118G5	517.52	9.23	0.98	4.52	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	431.96	17.72	2.53	4.43	0.63
Preadipocyte - breast, donor1	11467-119B9	950.13	40.33	0.19	4.88	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	262.75	37.59	0.13	5.09	0.13
Preadipocyte - breast, donor2	11328-117E5	663.74	24.09	1.80	7.88	0.90
Preadipocyte - omental, donor1	11468-119C1	947.73	54.13	0.64	7.78	0.32
Preadipocyte - omental, donor2	11329-117E6	621.53	40.16	0.44	6.11	0.44
Preadipocyte - omental, donor3	11403-118D8	478.45	44.69	0.72	8.59	0.14
Preadipocyte - perirenal, donor1	11469-119C2	530.52	28.54	1.97	6.89	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	366.08	38.70	0.00	13.51	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	926.65	84.82	2.66	37.36	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	1007.23	65.39	0.85	21.12	0.00
Preadipocyte - visceral, donor1	11280-116I2	1430.74	119.51	0.37	34.46	0.19
Preadipocyte - visceral, donor2	11357-117H7	788.75	65.81	0.46	18.41	0.00
Preadipocyte - visceral, donor3	11429-118G7	743.87	67.19	2.82	21.11	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	1987.78	60.79	2.56	19.91	0.75
Prostate Epithelial Cells, donor2	11331-117E8	415.99	34.12	0.95	16.39	0.14
Prostate Epithelial Cells, donor3	11404-118D9	1115.56	24.68	1.35	25.35	0.67
Prostate Stromal Cells, donor1	11254-116F3	1309.97	108.55	1.82	32.92	0.34
Prostate Stromal Cells, donor2	11332-117E9	900.62	60.60	3.23	23.67	0.54
Prostate Stromal Cells, donor3	11405-118E1	848.70	25.76	1.67	8.34	0.73
Renal Cortical Epithelial Cells, donor1	11516-119H4	307.32	8.39	0.00	6.57	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	1368.63	36.80	1.25	21.69	0.35
Renal Epithelial Cells, donor1	11517-119H5	151.15	2.03	0.00	3.04	0.00
Renal Epithelial Cells, donor2	11597-120H4	174.27	7.82	1.42	8.54	0.00
Renal Epithelial Cells, donor3	11678-122H4	1643.66	40.33	0.95	22.34	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	124.60	2.04	0.68	4.77	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	344.46	12.80	1.75	14.82	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	550.36	48.84	2.44	33.75	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	127.77	5.32	0.00	3.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	313.85	8.58	0.00	5.94	0.22
Renal Mesangial Cells, donor2	11598-120H5	262.71	1.88	0.00	10.03	0.00
Renal Mesangial Cells, donor3	11679-122H5	153.13	3.05	0.55	1.66	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	542.75	28.18	0.00	31.41	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	227.29	6.75	0.42	13.07	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	280.21	7.91	0.58	8.29	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	1842.20	52.37	2.07	50.04	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	847.33	19.33	0.85	14.21	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	229.49	4.12	1.03	11.32	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	3053.04	66.74	2.26	25.84	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	1264.73	22.85	0.94	4.94	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	1609.91	64.33	4.47	17.87	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	5154.22	254.82	30.82	52.84	3.85
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	3490.19	145.01	5.22	44.08	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	2710.90	205.31	2.73	49.28	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	1984.82	110.92	5.76	50.15	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	3548.51	262.90	3.12	59.67	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	3763.60	267.44	8.06	68.47	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	2426.58	134.61	6.88	46.04	1.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	2413.25	185.83	9.48	61.25	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	1858.26	105.42	3.29	46.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	2093.32	150.37	6.35	45.53	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	2364.42	190.12	2.33	44.62	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	2104.94	117.78	4.16	43.47	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	2291.16	143.80	7.40	52.26	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	2148.75	155.77	4.87	53.99	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	1701.66	87.37	1.15	43.40	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	1866.05	121.02	3.63	48.63	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	3727.70	261.19	2.63	61.26	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	1565.14	88.91	2.12	45.52	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	2132.84	126.15	4.58	50.13	1.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	2374.76	173.58	3.63	53.47	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	1763.69	110.96	1.50	41.12	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	1720.52	114.08	8.13	46.81	2.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	1888.09	138.94	4.44	51.44	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	1499.48	82.05	0.91	46.49	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	1877.62	108.28	4.05	42.31	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	2382.70	149.10	6.18	57.76	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	2362.26	161.10	2.83	50.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	2067.86	131.94	5.56	44.44	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	2079.12	171.41	7.02	62.44	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	2231.35	129.18	2.70	55.78	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	2427.11	159.05	18.36	57.51	5.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	1764.03	123.66	5.22	48.04	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	2012.85	133.91	4.04	49.12	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	1561.26	93.32	2.04	51.09	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	1790.87	129.75	4.63	54.56	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	2268.20	160.07	4.64	46.42	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	1300.09	87.38	1.23	48.01	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	2093.16	177.96	13.13	51.55	2.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	1815.43	90.67	4.43	34.09	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	2465.86	141.74	4.14	45.57	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	1534.80	103.69	2.40	50.11	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	2484.65	67.34	3.04	28.62	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	2817.22	101.67	9.76	41.19	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	2195.39	74.17	1.81	35.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	2575.29	74.49	3.86	23.26	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	3148.81	112.15	10.13	33.54	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	2512.90	77.97	4.23	40.19	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	2162.33	99.99	1.96	27.17	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	4371.82	202.61	3.35	36.68	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	2518.89	101.00	10.34	34.68	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	2112.51	94.04	3.01	31.04	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	2216.19	83.92	4.52	25.56	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	2079.41	53.62	2.10	20.37	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	3299.59	124.10	2.48	22.32	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	2192.29	76.41	2.35	23.69	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	2181.55	57.69	1.80	30.65	3.00
Schwann Cells, donor1	11498-119F4	231.14	5.83	0.94	5.83	0.00
Schwann Cells, donor2	11578-120F3	663.47	40.83	3.40	30.62	0.00
Schwann Cells, donor3	11659-122F3	536.31	39.65	3.07	20.59	1.53
Sebocyte, donor1	11220-116B5	1541.42	59.71	0.55	35.61	0.00
Sebocyte, donor2	11301-117B5	946.68	33.55	1.84	28.95	0.92
Sebocyte, donor3	11378-118B1	795.39	18.96	0.41	23.70	0.62
Sertoli Cells, donor1	11255-116F4	1222.57	57.98	0.00	16.57	1.66
Sertoli Cells, donor2	11333-117F1	1344.40	16.95	2.82	16.95	0.00
Skeletal Muscle Cells, donor1	11281-116I3	1767.56	55.34	1.06	18.39	0.26
Skeletal Muscle Cells, donor2	11358-117H8	363.59	6.51	2.89	2.89	0.72
Skeletal Muscle Cells, donor3	11430-118G8	592.75	25.92	1.67	15.88	0.00
Skeletal Muscle Cells, donor4	11451-119A2	1130.76	65.35	5.18	65.51	0.31
Skeletal Muscle Cells, donor5	11455-119A6	1095.66	50.69	6.39	54.85	0.30
Skeletal Muscle Cells, donor6	11459-119B1	1139.80	72.18	5.39	81.26	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	2537.51	54.06	1.39	35.66	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	1279.63	26.40	4.00	33.25	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	1057.58	65.78	2.48	60.91	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	1647.72	56.95	1.01	15.50	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	403.14	23.16	1.45	13.75	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	437.98	10.04	1.65	8.67	0.14
Skin - palm, donor1	10286-104F7	558.71	13.43	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	498.20	30.56	3.03	21.19	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	200.38	36.81	0.00	23.72	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	542.81	23.63	1.04	21.81	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	1702.85	71.73	1.67	32.81	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	654.20	30.52	2.53	17.44	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	468.56	57.30	0.00	26.22	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	609.80	18.66	0.97	13.79	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	1441.70	50.61	5.86	16.05	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	340.83	34.68	0.22	6.67	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	605.46	44.09	1.18	7.05	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	297.01	29.39	0.88	8.40	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	461.51	51.98	0.00	8.66	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	621.14	42.49	0.77	3.86	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	1431.08	13.01	9.01	3.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	675.24	48.17	0.00	11.71	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	961.31	54.08	3.32	19.51	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	802.62	51.60	1.15	29.45	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	1187.75	34.84	0.98	12.70	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	1027.44	71.47	0.89	20.08	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	613.73	33.31	0.71	10.53	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	182.03	6.34	0.00	6.83	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	795.18	17.96	0.91	11.87	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	783.45	37.13	1.01	10.36	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	55.09	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	421.52	24.80	0.95	11.92	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	1352.48	56.48	0.74	18.88	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	985.79	41.54	5.60	20.66	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	957.64	50.80	2.62	28.13	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	468.21	44.24	0.31	17.48	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	315.82	48.50	0.00	21.56	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	436.33	27.79	1.79	11.36	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	262.54	13.31	1.37	10.24	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	2711.92	24.50	2.75	12.56	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	1097.89	78.60	0.81	26.27	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	352.25	40.28	1.37	10.69	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	539.81	28.98	3.02	9.06	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	1674.06	181.47	0.26	107.29	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	1123.20	57.66	0.67	14.78	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	894.44	38.57	1.75	12.77	1.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	1242.19	16.49	0.76	6.34	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	945.95	69.20	0.90	17.04	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	381.09	16.50	1.50	11.25	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	311.42	12.92	0.00	14.21	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	547.85	41.39	0.47	10.23	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	570.01	46.45	1.51	17.67	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	247.58	22.88	0.31	11.91	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	222.13	5.60	0.59	8.26	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	1190.04	92.05	0.75	40.65	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	858.64	15.42	0.93	8.88	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	702.32	52.24	0.14	15.26	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	660.59	45.89	1.27	18.87	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	504.31	26.51	2.44	14.48	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	1843.65	97.40	0.84	43.46	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	2131.57	71.64	2.18	24.89	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	131.43	2.38	0.48	3.81	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	751.60	49.42	0.24	14.44	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	1228.69	76.67	0.88	15.02	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	902.90	48.57	1.17	19.02	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	520.50	12.24	2.72	3.89	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	354.10	30.41	1.32	6.35	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	977.48	49.10	4.09	6.70	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	575.66	38.81	1.44	10.78	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	284.47	43.72	0.57	10.50	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	604.59	60.26	3.54	22.06	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	717.92	29.71	2.03	9.14	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	575.02	8.39	2.40	5.99	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	595.24	16.30	5.85	5.85	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	657.29	16.04	0.92	1.38	1.38
Synoviocyte, donor1	11291-117A4	1178.92	58.91	1.51	10.60	0.50
Synoviocyte, donor2	11368-117I9	764.70	20.62	3.02	3.86	0.67
Synoviocyte, donor3	11440-118H9	865.27	13.40	4.24	4.02	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	306.23	18.58	0.00	13.94	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	269.56	5.95	0.00	3.96	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	239.88	4.86	0.00	6.95	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	1100.93	42.01	0.29	31.97	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	434.11	18.94	0.39	24.74	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	444.96	27.49	0.57	22.91	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	1289.79	24.48	0.62	5.17	0.12
Urethra, donor2	10319-105A4	899.21	5.40	0.00	7.19	0.00
Urothelial Cells, donor1	11520-119H8	232.19	5.31	0.00	8.77	0.00
Urothelial Cells, donor2	11600-120H7	202.69	3.61	0.00	7.61	0.40
Urothelial Cells, donor3	11681-122H7	178.32	1.60	0.23	3.44	0.23
Urothelial cells, donor0	11216-116B1	1516.80	18.05	1.34	19.39	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	1785.79	10.68	3.56	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	1709.81	8.58	0.00	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	869.34	8.21	10.27	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	1732.02	11.36	1.72	3.10	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	1952.83	10.46	2.91	2.91	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	1535.83	14.58	0.00	4.16	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	1815.39	11.01	3.67	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	922.03	2.74	4.56	1.83	0.91
Wilms' tumor cell line:G-401	10809-111A8	1479.10	55.39	1.60	32.07	1.11
Wilms' tumor cell line:HFWT	10597-108E3	652.11	19.36	0.00	17.60	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	1082.08	35.19	2.79	40.78	0.56
achilles tendon, donor2	10292-104G4	467.04	6.20	0.00	8.27	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	2430.50	99.69	2.04	31.87	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	3322.65	127.46	2.32	47.36	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	2837.60	44.40	0.83	21.49	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	2104.26	196.74	1.63	54.15	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	1155.82	109.62	5.06	46.38	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	2215.48	44.20	0.85	14.59	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	2838.35	45.19	2.99	11.71	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	3930.50	111.48	3.97	38.78	3.08
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	2267.21	60.85	2.45	25.32	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	2146.51	72.22	4.27	17.09	1.94
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	2078.10	146.46	6.26	132.30	1.10
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	3112.61	62.41	0.00	35.10	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	2040.08	99.69	5.11	39.04	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	2267.20	155.34	5.44	75.60	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	1964.46	99.95	7.31	56.11	3.21
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	866.78	19.06	0.93	21.38	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	1028.95	53.46	0.41	21.80	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	877.88	30.70	0.00	41.75	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	3200.32	157.88	2.13	65.29	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	3172.75	146.19	1.21	48.22	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	3843.11	196.42	2.17	74.62	1.68
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	1071.60	126.29	2.23	79.74	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	952.61	70.71	1.33	45.70	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	691.25	35.31	0.00	55.75	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	1343.55	119.40	2.64	76.46	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	1195.00	29.22	1.31	17.88	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	882.87	24.37	0.00	35.61	0.00
adenocarcinoma cell line:IM95m	10796-110I4	1155.83	32.50	2.12	14.37	0.94
adipose tissue, adult, pool1	10010-101C1	1117.63	16.60	0.31	2.64	0.47
adipose, donor1	10184-103D4	4178.17	46.91	9.97	43.98	1.76
adipose, donor2	10185-103D5	666.67	4.87	2.03	11.35	0.41
adipose, donor3	10186-103D6	908.90	28.05	3.00	22.33	1.09
adipose, donor4	10187-103D7	1160.58	61.54	3.47	64.14	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	1491.08	51.13	1.10	46.40	0.63
adrenal gland, adult, pool1	10081-102A9	694.79	7.28	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	1407.70	18.68	0.53	9.47	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	1410.62	59.31	2.14	27.87	1.07
amniotic membrane cells, donor1	12235-129G3	749.80	16.93	1.39	4.17	1.16
amniotic membrane cells, donor2	12236-129G4	922.35	13.19	0.34	3.72	0.68
amniotic membrane cells, donor3	12237-129G5	1146.00	16.20	2.06	3.83	0.00
amygdala - adult, donor10196	10167-103B5	291.71	29.64	2.37	29.64	0.00
amygdala, adult, donor10252	10151-102I7	480.96	18.25	0.61	12.57	0.81
amygdala, newborn, donor10223	10360-105E9	242.08	15.82	0.00	10.97	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	2251.57	23.43	1.27	13.75	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	1363.67	136.79	3.75	40.37	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	2226.02	27.73	1.67	11.36	1.34
aorta, adult, pool1	10052-101G7	714.71	3.92	2.35	2.94	0.98
appendix, adult	10189-103D9	922.94	13.58	1.94	7.76	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	3232.65	70.16	0.69	27.51	1.03
artery, adult	10190-103E1	756.79	14.95	2.72	9.51	1.36
astrocytoma cell line:TM-31	10425-106D2	2976.73	114.45	1.74	22.02	0.14
b cell line:RPMI1788	10427-106D4	2979.68	43.72	1.34	28.25	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	723.58	54.10	0.00	9.99	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	1655.18	92.48	0.60	35.72	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	1109.89	54.57	1.67	3.35	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	1374.61	26.28	1.68	16.22	1.68
bladder, adult, pool1	10011-101C2	1821.48	16.08	1.09	5.54	0.76
blood, adult, pool1	10053-101G8	943.43	6.64	4.43	4.43	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	281.74	28.26	0.00	6.85	0.00
bone marrow, adult	10192-103E3	832.74	29.69	3.37	7.42	0.67
brain, adult, donor1	10084-102B3	274.72	11.28	1.03	8.20	0.00
brain, adult, pool1	10012-101C3	558.13	19.82	0.45	8.02	0.11
brain, fetal, pool1	10085-102B4	774.71	5.34	0.00	16.03	0.00
breast carcinoma cell line:MCF7	10482-107A5	1145.04	12.55	1.32	7.27	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	1287.05	25.34	0.50	6.87	0.25
breast, adult, donor1	10080-102A8	791.09	4.42	1.89	1.89	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	866.91	60.09	1.27	30.62	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	1409.12	33.71	3.09	29.07	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	2019.02	40.75	2.53	25.55	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	380.56	24.69	0.73	6.78	0.48
carcinoid cell line:NCI-H1770	10703-109H1	2057.92	25.86	0.47	52.19	0.94
carcinoid cell line:NCI-H727	10735-110B6	426.91	15.20	1.09	11.27	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	2042.71	61.79	1.58	32.64	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	2429.94	36.73	11.45	24.22	0.53
caudate nucleus - adult, donor10196	10177-103C6	419.08	13.82	0.00	14.97	0.00
caudate nucleus, adult, donor10252	10164-103B2	501.64	17.23	1.51	7.03	0.33
caudate nucleus, adult, donor10258	10379-105H1	571.58	16.81	1.53	10.70	0.00
caudate nucleus, newborn, donor10223	10354-105E3	502.84	22.71	0.37	8.79	0.00
cerebellum - adult, donor10196	10173-103C2	492.34	20.39	0.00	14.57	0.00
cerebellum, adult, donor10252	10166-103B4	623.45	19.00	0.85	8.54	0.21
cerebellum, adult, pool1	10083-102B2	506.03	8.62	1.38	9.31	0.00
cerebellum, newborn, donor10223	10357-105E6	528.89	16.61	0.83	7.47	0.00
cerebral meninges, adult	10188-103D8	688.84	12.35	0.00	10.84	0.50
cerebrospinal fluid, donor2	10294-104G6	397.60	14.62	0.00	5.85	0.00
cervical cancer cell line:D98-AH2	10552-107I3	2581.18	105.54	1.15	20.13	1.01
cervical cancer cell line:ME-180	10553-107I4	1762.73	40.27	1.16	13.26	0.17
cervix, adult, pool1	10013-101C4	1994.18	16.69	1.57	5.56	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	1345.45	78.59	0.84	15.47	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	205.08	3.92	0.00	9.14	0.00
choriocarcinoma cell line:BeWo	10423-106C9	4961.47	91.22	3.60	93.08	0.62
choriocarcinoma cell line:SCH	10785-110H2	1786.70	55.32	3.45	19.34	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	1157.43	30.60	1.90	33.20	0.47
chorionic membrane cells, donor1	12238-129G6	629.67	20.80	1.99	4.84	1.14
chorionic membrane cells, donor2	12239-129G7	681.30	39.47	0.70	7.06	0.30
chorionic membrane cells, donor3	12240-129G8	1044.57	17.58	4.95	5.49	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	1521.77	121.18	14.14	35.34	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	1428.45	62.62	2.11	34.58	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	1780.51	66.31	1.90	39.91	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	1071.63	84.49	1.28	92.19	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	1216.89	87.56	2.66	83.45	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	1267.88	103.03	1.43	72.69	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	2414.24	200.82	1.47	120.14	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	3556.76	143.08	1.04	43.26	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	723.23	34.29	3.66	17.37	0.69
clear cell carcinoma cell line:TEN	10636-108I6	2268.42	66.11	2.78	15.96	0.69
colon carcinoma cell line:CACO-2	10513-107D9	1262.99	84.93	0.37	22.70	0.92
colon carcinoma cell line:COLO-320	10420-106C6	5600.50	66.13	1.52	68.79	1.14
colon, adult, donor1	10082-102B1	696.17	13.09	4.76	0.00	0.00
colon, adult, pool1	10014-101C5	1292.77	15.75	0.59	2.47	0.47
colon, fetal, donor1	10070-101I7	1058.61	6.18	3.71	6.18	0.00
common myeloid progenitor CMP, donor1	12130-128D6	618.78	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	5382.89	125.18	25.04	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	1765.17	136.83	0.85	24.65	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	1786.43	170.40	0.60	36.53	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	1932.98	188.81	0.71	37.37	0.14
corpus callosum, adult, pool1	10042-101F6	634.74	13.49	0.22	4.75	0.00
cruciate ligament, donor2	10295-104G7	485.47	11.35	0.00	4.86	0.00
diaphragm, fetal, donor1	10069-101I6	786.51	8.83	2.41	10.43	0.00
diencephalon, adult	10193-103E4	305.27	14.40	0.24	9.84	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	3261.40	79.22	16.76	42.71	5.05
ductal cell carcinoma cell line:KLM-1	10438-106E6	2193.07	104.63	1.03	44.88	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	2048.30	91.23	0.72	10.83	0.48
ductus deferens, adult	10196-103E7	818.77	9.47	3.49	4.98	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	1038.41	7.20	2.88	12.96	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	1405.83	26.48	8.09	6.62	2.94
dura mater, adult, donor1	10041-101F5	1350.63	19.08	0.58	5.20	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	1706.63	188.10	1.33	49.30	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	2284.96	207.06	0.72	78.95	0.86
embryonic pancreas cell line:1B2C6	10604-108F1	630.18	12.33	1.23	30.83	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	1002.58	24.82	4.24	14.53	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	741.31	27.17	1.54	24.39	0.00
embryonic pancreas cell line:2C6	10603-108E9	542.46	13.13	0.00	27.58	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	1849.27	90.84	1.34	24.13	2.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	1879.05	32.62	2.90	15.59	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	1138.24	85.07	4.82	14.63	0.80
epidermoid carcinoma cell line:A431	10426-106D3	1377.59	61.47	0.56	23.23	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	1222.82	85.79	0.99	35.53	0.22
epididymis, adult	10197-103E8	919.71	12.77	1.88	5.02	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	476.52	15.43	0.53	5.14	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	622.89	35.39	1.18	16.12	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	1510.22	151.62	6.95	49.14	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	1638.20	117.81	3.15	36.91	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	1401.94	135.00	3.92	49.52	1.23
esophagus, adult, pool1	10015-101C6	1479.17	23.25	1.49	6.05	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	2862.77	30.18	0.50	6.76	0.75
eye - muscle inferior rectus, donor1	10272-104E2	350.11	16.90	0.00	14.49	0.00
eye - muscle lateral, donor2	10298-104H1	284.07	14.73	0.00	12.63	0.00
eye - muscle medial, donor2	10299-104H2	160.73	1.49	0.00	11.91	0.00
eye - muscle superior, donor2	10297-104G9	312.99	10.32	0.00	11.46	0.00
eye - vitreous humor, donor1	10268-104D7	371.63	11.66	1.46	11.66	0.00
eye, fetal, donor1	10054-101G9	1006.77	7.63	4.07	5.34	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	1130.68	54.88	0.77	29.11	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	1049.63	87.37	1.66	51.05	0.47
frontal lobe, adult, pool1	10040-101F4	585.65	18.95	0.00	10.32	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	774.34	66.96	1.50	15.91	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	1880.12	69.31	0.64	29.44	0.18
gall bladder, adult	10198-103E9	735.16	18.35	2.90	4.83	0.24
gamma delta positive T cells, donor1	11937-126A2	2531.27	23.62	2.15	6.44	3.22
gamma delta positive T cells, donor2	11938-126A3	1559.33	16.06	1.87	6.72	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	1108.46	41.40	4.44	19.43	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	1244.63	38.30	3.48	12.96	0.97
gastric cancer cell line:AZ521	10549-107H9	2626.56	170.35	1.48	43.61	0.33
gastric cancer cell line:GSS	10560-108A2	1350.87	35.69	9.15	16.47	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	1894.14	55.29	8.68	11.42	0.91
giant cell carcinoma cell line:LU65	10487-107B1	1826.55	92.02	0.92	51.17	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	1651.66	24.77	0.42	28.55	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	670.93	28.93	0.75	24.69	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	346.85	26.92	0.11	5.91	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	299.13	21.21	0.00	5.48	0.14
glioblastoma cell line:T98G	10485-107A8	1368.30	91.39	0.66	19.32	0.22
glioma cell line:GI-1	10413-106B8	1488.11	35.73	0.29	9.08	0.59
globus pallidus - adult, donor10196	10175-103C4	357.17	12.39	0.73	5.10	0.00
globus pallidus, adult, donor10252	10161-103A8	678.09	25.14	1.71	7.57	0.49
globus pallidus, adult, donor10258	10367-105F7	542.21	13.69	1.37	2.74	1.37
globus pallidus, newborn, donor10223	10364-105F4	317.62	19.19	0.00	9.06	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	323.02	7.34	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	2524.45	43.71	10.93	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	3946.07	47.04	5.23	5.23	5.23
granulosa cell tumor cell line:KGN	10624-108H3	503.35	21.44	0.96	12.16	0.96
hIPS +CCl2, biol_rep1	14383-156B9	1083.51	65.19	1.84	92.74	0.46
hIPS +CCl2, biol_rep2	14384-156C1	1013.75	102.43	7.77	96.48	0.46
hIPS +CCl2, biol_rep3	14385-156C2	705.28	71.49	2.58	128.17	0.64
hIPS, biol_rep1	14380-156B6	445.56	140.85	4.31	208.41	0.00
hIPS, biol_rep2	14381-156B7	597.39	80.93	4.80	98.76	0.00
hIPS, biol_rep3	14382-156B8	445.80	28.69	0.00	25.38	0.00
hairy cell leukemia cell line:Mo	10712-109I1	1268.91	40.23	2.87	17.53	0.29
heart - mitral valve, adult	10205-103F7	520.20	12.86	0.60	3.89	0.30
heart - pulmonic valve, adult	10206-103F8	785.21	15.43	1.31	4.71	0.52
heart - tricuspid valve, adult	10207-103F9	468.78	30.81	4.16	4.16	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	508.71	26.53	2.04	9.79	0.41
heart, adult, diseased, donor1	10051-101G6	370.90	8.09	1.70	4.68	0.00
heart, adult, pool1	10016-101C7	347.04	11.50	0.46	3.91	0.00
heart, fetal, pool1	10046-101G1	1864.98	15.71	1.13	8.83	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	546.09	22.83	0.31	8.95	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	2529.38	20.22	1.19	41.62	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	1184.52	94.58	3.43	29.61	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	1227.33	102.93	2.18	29.49	1.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	1374.02	102.77	2.93	31.63	0.61
hepatoma cell line:Li-7	10484-107A7	443.19	40.70	0.44	6.01	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	1673.03	101.00	2.11	63.82	0.40
hippocampus - adult, donor10196	10169-103B7	328.38	20.82	0.00	17.98	0.00
hippocampus, adult, donor10252	10153-102I9	528.62	21.23	0.82	6.94	0.00
hippocampus, adult, donor10258	10374-105G5	236.03	16.43	1.49	11.95	0.00
hippocampus, newborn, donor10223	10363-105F3	256.60	16.21	1.06	9.52	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	2888.15	192.26	21.97	165.40	6.71
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	1558.66	77.76	3.53	75.60	3.34
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	1771.68	98.26	7.87	85.31	2.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	1566.98	15.22	5.64	25.94	2.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	2403.43	28.66	37.18	27.11	13.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	2630.32	26.57	9.49	31.13	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	1395.54	16.06	4.09	14.60	2.34
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	1530.62	14.65	3.45	16.59	2.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	1093.15	23.77	2.09	16.68	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	1997.11	71.75	2.84	24.15	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	1542.24	42.11	3.70	23.95	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	1770.78	51.84	0.67	18.18	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	1658.42	86.69	4.23	65.57	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	1621.76	134.61	41.27	85.49	4.42
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	3250.13	203.35	8.73	141.39	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	1842.86	16.99	2.67	17.56	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	1388.02	11.77	4.80	21.37	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	1755.16	22.99	9.00	22.49	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	1710.78	10.55	3.39	18.46	3.58
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	1606.06	13.19	5.46	22.28	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	1281.13	6.89	1.88	16.60	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	1185.24	29.23	3.27	13.06	1.96
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	1119.14	23.52	2.61	9.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	917.69	17.94	1.79	14.65	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	1603.58	85.72	6.65	73.90	2.96
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	1282.07	76.74	4.85	72.46	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	2137.10	134.33	10.21	111.47	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	1476.98	34.86	17.60	28.52	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	1233.07	21.54	3.80	25.02	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	1424.43	23.91	5.14	22.39	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	1018.21	17.07	1.55	16.03	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	1044.73	15.94	2.66	13.28	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	1130.54	17.96	3.08	14.37	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	1071.17	44.99	7.67	28.38	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	1151.74	34.08	3.03	15.14	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	960.12	43.69	2.02	22.85	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	1512.07	95.88	2.17	73.90	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	1955.11	116.76	15.60	99.38	3.12
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	1348.30	84.39	2.93	87.81	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	1470.63	19.56	3.06	21.09	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	16500.45	201.70	100.85	204.95	29.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	2570.10	28.79	8.60	40.37	3.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	1246.75	20.25	1.64	20.80	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	1241.26	14.11	2.90	17.73	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	1384.34	13.17	4.98	18.51	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	1138.49	32.22	5.97	31.03	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	1883.77	48.08	2.17	24.11	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	968.48	27.75	2.16	14.82	1.35
immature langerhans cells, donor1	11904-125F5	1078.52	18.40	1.45	3.63	0.73
immature langerhans cells, donor2	11905-125F6	643.21	7.92	1.58	0.79	0.79
insula, adult, pool1	10039-101F3	528.34	17.13	0.57	8.52	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	944.23	23.41	1.30	16.91	0.33
kidney, adult, pool1	10017-101C8	1025.81	25.83	0.80	5.51	0.40
kidney, fetal, pool1	10045-101F9	1306.84	8.91	0.42	4.31	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	1986.73	66.47	0.14	23.29	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	1106.07	26.68	4.01	3.59	0.83
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	1199.35	26.24	0.55	26.61	0.37
left atrium, adult, donor1	10079-102A7	616.23	9.81	2.18	6.54	0.54
left ventricle, adult, donor1	10078-102A6	518.80	12.14	0.51	9.61	0.00
leiomyoblastoma cell line:G-402	10721-110A1	866.25	43.23	0.27	43.23	0.82
leiomyoma cell line:10964C	10569-108B2	796.10	41.67	3.59	12.21	0.72
leiomyoma cell line:15242A	10570-108B3	554.89	47.83	2.17	13.04	0.54
leiomyoma cell line:15425	10571-108B4	756.13	57.79	3.64	16.27	2.19
leiomyosarcoma cell line:Hs 5.T	10722-110A2	634.94	50.79	0.00	12.70	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	423.45	16.73	1.05	3.14	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	3193.12	142.38	3.90	47.93	2.13
liposarcoma cell line:KMLS-1	10782-110G8	845.25	26.24	0.78	6.56	0.47
liposarcoma cell line:SW 872	10726-110A6	640.02	23.88	0.85	8.16	0.61
liver, adult, pool1	10018-101C9	870.76	45.54	0.65	8.27	0.49
liver, fetal, pool1	10086-102B5	514.57	8.47	1.88	9.41	0.94
locus coeruleus - adult, donor10196	10182-103D2	439.95	12.54	0.87	13.56	0.15
locus coeruleus, adult, donor10252	10165-103B3	447.72	15.32	1.48	5.17	0.18
locus coeruleus, adult, donor10258	10375-105G6	329.82	11.29	1.13	11.57	0.56
locus coeruleus, newborn, donor10223	10362-105F2	578.35	40.38	0.84	10.52	0.00
lung adenocarcinoma cell line:A549	10499-107C4	754.67	25.05	0.42	4.71	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	801.09	32.40	0.69	6.89	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	676.22	18.06	0.92	15.69	0.40
lung, adult, pool1	10019-101D1	1112.29	11.93	0.59	3.66	0.71
lung, fetal, donor1	10068-101I5	2546.40	22.55	0.29	9.13	0.00
lung, right lower lobe, adult, donor1	10075-102A3	645.17	11.46	1.37	4.58	0.46
lymph node, adult, donor1	10077-102A5	1181.99	16.09	4.26	6.15	0.47
lymphangiectasia cell line:DS-1	10727-110A7	1676.05	31.12	1.97	17.10	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	2694.04	110.78	1.81	26.26	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	950.59	58.62	0.00	11.89	0.00
mature adipocyte, donor1	12231-129F8	491.50	7.55	0.44	2.66	0.00
mature adipocyte, donor2	12232-129F9	554.52	17.64	0.21	4.57	0.21
mature adipocyte, donor3	12233-129G1	620.16	18.02	0.24	2.84	0.24
mature adipocyte, donor4	12234-129G2	983.38	17.90	0.53	3.69	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	2759.52	106.50	1.43	29.78	1.19
medial frontal gyrus - adult, donor10196	10170-103B8	347.43	16.92	0.00	9.02	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	509.24	23.72	0.74	8.09	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	269.72	14.30	1.27	11.75	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	813.31	49.47	4.26	20.47	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	639.90	24.47	5.40	16.71	1.52
medial temporal gyrus, adult, donor10252	10156-103A3	435.06	19.95	0.85	7.22	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	188.77	17.34	0.00	32.75	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	4779.75	244.01	0.00	71.77	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	267.76	14.00	0.36	8.97	0.72
medulla oblongata - adult, donor10196	10174-103C3	478.30	18.82	1.30	9.09	0.00
medulla oblongata, adult, donor10252	10155-103A2	570.30	15.79	0.77	5.57	0.31
medulla oblongata, adult, pool1	10038-101F2	561.76	15.43	0.24	5.80	0.00
medulla oblongata, newborn, donor10223	10361-105F1	364.19	11.80	0.35	4.86	0.00
medulloblastoma cell line:D283 Med	10838-111E1	3496.98	77.72	9.30	38.97	0.22
medulloblastoma cell line:ONS-76	10759-110E3	320.60	27.27	0.24	20.54	0.24
melanoma cell line:COLO 679	10514-107E1	778.82	42.41	0.57	7.91	0.00
melanoma cell line:G-361	10465-106H6	1265.02	64.07	1.36	17.92	0.81
meningioma cell line:HKBMM	10691-109F7	684.72	35.28	5.97	12.48	1.27
merkel cell carcinoma cell line:MKL-1	10843-111E6	1562.29	45.82	6.17	12.34	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	677.35	44.59	0.78	13.22	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	1185.28	83.62	1.99	28.39	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	1260.10	47.81	2.18	10.91	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	762.36	55.08	1.24	19.46	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	984.45	25.99	2.39	6.46	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	941.27	22.15	4.04	4.24	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	455.32	28.46	2.08	5.55	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	934.55	22.66	3.43	6.35	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	941.52	39.45	2.07	8.51	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	884.95	68.71	3.45	15.65	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	735.16	64.55	2.43	15.12	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	754.28	47.80	1.56	13.80	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	715.03	14.82	0.66	3.95	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	739.04	39.99	1.80	12.73	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	624.16	53.76	1.40	14.31	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	842.79	29.40	1.43	8.98	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	551.76	22.65	0.72	4.67	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	777.01	23.38	1.86	6.10	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	337.20	37.39	1.14	8.89	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	990.99	151.46	2.10	37.34	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	694.59	34.07	2.54	12.25	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	917.23	35.01	1.93	9.28	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	879.17	19.88	1.47	5.89	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	508.50	32.05	1.43	8.58	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	940.13	53.89	4.63	21.47	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	687.29	30.14	1.83	10.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	862.76	32.74	0.26	6.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	730.04	22.77	0.26	10.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	711.06	24.65	1.23	9.55	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	889.17	40.01	3.06	9.65	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	765.93	30.46	1.02	8.80	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	747.04	26.72	1.96	8.65	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	839.65	29.19	1.85	6.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	1207.59	241.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	993.60	43.26	0.87	11.83	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	765.90	31.90	0.67	8.25	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	797.01	28.84	1.44	9.13	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	698.86	27.87	2.20	7.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	754.22	21.48	0.34	7.05	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	799.93	29.07	2.46	9.83	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	812.29	21.48	1.72	7.73	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	601.57	38.28	0.00	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	588.81	41.32	5.16	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	748.31	33.13	1.62	8.44	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	742.04	29.10	0.00	17.46	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	673.28	32.52	1.07	10.13	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	623.96	29.44	1.64	5.72	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	665.88	24.88	1.94	10.11	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	625.42	20.99	6.30	6.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	589.13	32.78	0.00	8.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	681.71	57.21	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	705.04	24.31	1.78	5.93	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	746.92	37.77	1.22	6.09	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	432.84	54.10	0.00	54.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	776.53	32.94	2.53	10.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	807.42	25.52	1.72	4.48	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	831.74	15.04	0.00	8.60	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	662.64	35.93	3.99	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	743.88	20.66	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	904.99	27.30	2.85	6.52	2.04
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	928.70	27.81	2.38	6.36	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	947.37	23.58	5.31	4.13	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	980.00	23.38	2.81	2.18	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	870.17	18.71	9.36	6.68	4.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	766.37	39.03	0.00	14.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	927.05	77.04	2.57	15.41	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	1053.93	49.56	3.44	9.64	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	914.40	41.56	5.44	8.91	2.47
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	716.64	33.65	6.73	12.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	803.98	36.26	5.72	7.63	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	462.22	29.01	2.42	8.87	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	560.41	32.71	0.00	17.44	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	371.25	35.48	1.27	6.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	493.40	21.24	1.21	3.03	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	479.01	22.59	9.04	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	471.97	23.06	3.29	4.12	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	769.89	23.81	1.39	5.36	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	604.53	24.66	1.30	4.54	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	672.29	14.26	1.02	6.11	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	361.32	8.51	0.00	3.09	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	996.70	48.90	0.47	19.14	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	455.47	23.17	0.23	3.48	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	576.94	59.83	0.00	25.64	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	688.22	65.86	2.88	16.34	0.00
mesothelioma cell line:Mero-25	10850-111F4	468.89	36.54	0.91	17.70	0.23
mesothelioma cell line:Mero-41	10851-111F5	743.69	36.43	1.71	19.07	0.49
mesothelioma cell line:Mero-48a	10852-111F6	675.36	76.84	1.11	29.67	0.44
mesothelioma cell line:Mero-82	10853-111F7	742.69	68.59	1.58	22.86	0.79
mesothelioma cell line:Mero-83	10854-111F8	965.32	69.96	4.60	29.28	0.34
mesothelioma cell line:Mero-84	10855-111F9	395.09	23.76	0.00	10.36	0.00
mesothelioma cell line:Mero-95	10856-111G1	900.43	35.20	1.04	19.25	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	603.62	52.84	0.83	26.67	0.50
mesothelioma cell line:NCI-H226	10846-111E9	622.79	67.87	1.45	18.46	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	555.17	41.17	1.37	12.13	0.00
mesothelioma cell line:NCI-H28	10845-111E8	1231.11	53.44	3.56	21.88	0.51
mesothelioma cell line:No36	10857-111G2	484.41	51.54	2.94	19.57	0.00
mesothelioma cell line:ONE58	10858-111G3	588.24	64.22	2.17	20.05	0.00
migratory langerhans cells, donor1	11901-125F2	776.13	18.23	0.38	3.45	0.19
migratory langerhans cells, donor2	11902-125F3	436.44	10.62	0.12	2.20	0.24
migratory langerhans cells, donor3	11903-125F4	1366.92	17.95	0.18	4.13	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	444.99	17.30	4.24	14.04	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	711.89	58.07	3.39	23.52	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	979.25	44.92	1.38	36.63	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	1084.29	38.25	0.95	10.85	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	3502.18	104.04	1.48	21.99	1.48
myeloma cell line:PCM6	10474-106I6	1825.46	44.67	1.38	4.94	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	307.92	16.23	2.54	14.71	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	912.64	42.37	1.18	15.30	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	1394.48	36.77	0.33	27.97	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	1586.64	41.33	0.88	30.08	0.51
nasal epithelial cells, donor2	12227-129F4	922.93	36.98	0.55	15.46	0.00
neuroblastoma cell line:CHP-134	10508-107D4	4360.11	40.26	1.84	12.42	0.69
neuroblastoma cell line:NB-1	10539-107G8	1249.92	57.25	0.56	23.57	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	2772.98	146.99	6.75	59.47	2.95
neuroblastoma cell line:NH-12	10555-107I6	4563.92	44.17	8.01	19.94	1.49
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	2238.22	24.67	6.41	14.23	2.61
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	2134.97	30.41	6.49	18.69	1.58
neuroectodermal tumor cell line:TASK1	10774-110F9	2765.91	50.11	3.42	26.77	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	684.08	22.89	0.00	40.05	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	570.66	30.88	0.27	12.78	0.53
neutrophil PMN, donor1	12133-128D9	163.62	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	491.38	13.28	13.28	13.28	0.00
neutrophil PMN, donor3	12141-128E8	445.12	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	4558.30	47.02	1.35	39.57	1.35
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	909.38	60.04	1.60	16.81	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	862.11	32.06	1.60	8.02	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	606.46	36.79	1.05	8.15	0.53
nucleus accumbens, adult, pool1	10037-101F1	615.21	18.65	0.28	10.03	0.09
occipital cortex - adult, donor10196	10172-103C1	455.34	12.36	0.00	16.48	0.00
occipital cortex, adult, donor10252	10163-103B1	488.15	17.44	0.81	9.39	0.54
occipital cortex, newborn, donor10223	10355-105E4	347.57	12.74	0.73	10.55	0.36
occipital lobe, adult, donor1	10076-102A4	357.39	9.71	1.31	8.66	0.26
occipital lobe, fetal, donor1	10073-102A1	1533.17	8.15	2.15	21.88	1.29
occipital pole, adult, pool1	10036-101E9	329.79	6.39	0.08	6.62	0.00
olfactory region, adult	10195-103E6	357.84	16.05	1.15	12.80	0.00
optic nerve, donor1	10277-104E7	266.14	4.00	0.00	6.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	2685.84	96.94	1.37	15.49	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	1651.80	44.51	0.27	22.94	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	1407.42	43.52	7.96	13.72	2.88
oral squamous cell carcinoma cell line:SAS	10544-107H4	2035.49	67.23	4.74	35.23	1.27
osteoclastoma cell line:Hs 706.T	10704-109H2	454.77	13.52	0.00	4.41	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	1675.26	54.19	0.00	22.42	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	2290.03	72.74	1.27	22.27	0.21
ovary, adult, pool1	10020-101D2	2946.19	20.61	1.57	6.38	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	665.64	33.00	1.47	22.92	0.18
pancreas, adult, donor1	10049-101G4	2873.65	17.87	12.23	1.88	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	1446.32	39.69	1.68	22.92	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	1063.86	73.59	4.94	17.38	1.36
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	887.02	20.20	0.33	3.81	0.00
paracentral gyrus, adult, pool1	10035-101E8	458.43	14.64	0.09	8.15	0.09
parietal cortex, adult, donor10258	10373-105G4	366.27	19.82	1.47	18.35	0.00
parietal lobe - adult, donor10196	10171-103B9	293.43	14.11	1.88	16.93	0.00
parietal lobe, adult, donor10252	10157-103A4	465.75	19.38	0.00	12.26	0.29
parietal lobe, adult, pool1	10034-101E7	424.47	13.04	0.09	8.02	0.00
parietal lobe, fetal, donor1	10072-101I9	1862.08	7.76	1.94	22.31	2.91
parietal lobe, newborn, donor10223	10356-105E5	347.32	14.95	0.00	11.22	0.00
parotid gland, adult	10199-103F1	1309.79	10.48	3.08	6.78	1.85
penis, adult	10200-103F2	780.96	13.96	4.30	7.52	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	1934.48	30.49	4.28	24.92	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	558.59	22.58	1.02	10.64	0.58
pineal gland - adult, donor10196	10179-103C8	334.77	20.64	0.00	19.35	0.00
pineal gland, adult, donor10252	10160-103A7	853.38	23.69	0.59	6.51	0.59
pineal gland, adult, donor10258	10377-105G8	524.86	19.44	1.88	11.91	0.00
pituitary gland - adult, donor10196	10180-103C9	1309.27	31.37	3.04	14.17	0.00
pituitary gland, adult, donor10252	10162-103A9	1850.71	24.50	0.52	11.99	0.52
pituitary gland, adult, donor10258	10378-105G9	1316.87	14.47	6.81	14.47	0.00
placenta, adult, pool1	10021-101D3	835.51	25.05	1.40	6.13	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	1421.34	56.02	3.58	41.32	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	1054.61	14.94	0.31	7.63	0.47
pons, adult, pool1	10033-101E6	477.42	18.68	0.09	8.43	0.00
postcentral gyrus, adult, pool1	10032-101E5	409.64	10.20	0.09	8.28	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	148.49	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	4334.83	55.08	0.00	11.02	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	3626.35	23.47	11.74	35.21	11.74
prostate cancer cell line:DU145	10490-107B4	1109.80	44.28	1.46	30.15	0.29
prostate cancer cell line:PC-3	10439-106E7	980.29	80.41	1.09	17.06	0.36
prostate, adult, pool1	10022-101D4	1848.75	15.78	0.73	4.81	0.27
putamen, adult, donor10196	10176-103C5	606.45	23.61	0.71	12.04	0.47
putamen, adult, donor10252	10152-102I8	435.28	25.49	1.96	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	503.79	33.88	0.00	72.13	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	458.82	15.70	2.42	7.97	0.24
putamen, newborn, donor10223	10365-105F5	743.66	42.73	0.00	11.99	0.75
rectal cancer cell line:TT1TKB	10469-106I1	1938.79	42.19	1.75	12.51	0.00
rectum, fetal, donor1	10067-101I4	1780.47	5.56	6.95	5.56	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	1152.42	45.16	0.85	23.32	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	1032.63	4.56	1.24	8.70	1.24
retina, adult, pool1	10030-101E3	840.03	8.25	0.30	4.17	0.20
retinoblastoma cell line:Y79	10475-106I7	3904.57	63.39	1.04	39.23	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	946.33	51.76	1.11	24.59	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	2701.21	81.27	0.56	27.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	572.94	6.06	0.00	6.06	0.00
salivary acinar cells, donor1	11771-123I7	1387.11	29.62	3.72	6.15	0.16
salivary acinar cells, donor2	11772-123I8	1473.81	20.79	4.82	4.13	0.41
salivary acinar cells, donor3	11773-123I9	474.03	6.62	0.66	2.65	0.66
salivary gland, adult, pool1	10093-102C3	1575.16	16.01	1.72	5.15	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	1475.45	45.61	0.34	14.42	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	1539.22	45.49	0.47	13.75	0.24
seminal vesicle, adult	10201-103F3	791.49	13.76	1.59	3.70	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	999.64	56.36	5.59	19.68	2.43
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	578.75	15.35	0.25	8.81	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	434.53	46.16	1.00	13.05	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	1365.10	26.06	2.28	6.58	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	1122.08	52.17	0.00	11.61	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	1579.91	74.19	0.52	12.52	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	515.69	40.43	0.71	8.51	0.00
skeletal muscle, adult, pool1	10023-101D5	1065.64	29.98	0.60	7.92	0.48
skeletal muscle, fetal, donor1	10066-101I3	1502.50	12.06	2.01	5.03	2.01
skin, adult, donor1	10074-102A2	1580.95	13.57	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	1410.79	19.57	3.16	11.99	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	625.69	40.02	1.67	14.01	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	1327.01	38.77	2.52	5.36	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	2141.04	73.05	6.17	44.72	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	2150.99	36.26	0.16	14.50	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	3423.69	32.65	4.83	81.71	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	871.89	53.83	2.40	11.11	0.00
small intestine, adult, pool1	10024-101D6	1209.60	23.17	0.60	5.61	0.48
small intestine, fetal, donor1	10064-101I1	1582.77	17.94	2.95	6.39	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	856.03	31.29	5.13	5.13	1.03
smooth muscle, adult, pool1	10048-101G3	1359.73	11.89	4.65	5.43	0.78
somatostatinoma cell line:QGP-1	10781-110G7	857.13	19.30	0.54	8.04	0.00
spinal cord - adult, donor10196	10181-103D1	884.82	13.53	2.75	11.47	1.15
spinal cord, adult, donor10252	10159-103A6	776.32	19.71	0.00	4.73	0.00
spinal cord, adult, donor10258	10369-105F9	576.96	14.53	0.69	13.14	0.00
spinal cord, fetal, donor1	10056-101H2	582.39	12.81	0.00	9.76	0.61
spinal cord, newborn, donor10223	10359-105E8	575.39	19.75	1.84	9.18	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	463.60	24.79	0.60	11.20	0.15
spleen, adult, pool1	10025-101D7	1272.49	19.38	0.55	5.62	0.66
spleen, fetal, pool1	10044-101F8	857.72	11.76	0.48	5.24	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	1661.16	47.51	0.83	14.28	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	1287.55	41.20	0.19	12.34	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	868.74	59.76	3.84	13.28	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	1245.12	37.53	1.56	41.05	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	1191.32	119.99	0.34	29.27	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	861.18	68.62	5.93	8.47	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	514.03	26.65	1.27	10.58	0.00
stomach, fetal, donor1	10062-101H8	973.99	8.54	1.07	10.68	0.00
submaxillary gland, adult	10202-103F4	1123.41	11.39	3.42	5.13	1.14
substantia nigra - adult, donor10196	10178-103C7	705.56	108.55	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	555.41	19.52	1.04	3.53	0.21
substantia nigra, adult, donor10258	10371-105G2	286.04	23.28	0.00	15.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	338.45	14.84	0.71	9.19	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	1197.91	57.55	0.23	21.32	0.69
temporal lobe, adult, pool1	10031-101E4	325.77	9.49	0.34	9.49	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	971.53	5.70	1.42	12.11	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	733.59	7.47	2.64	10.11	0.88
tenocyte, donor1	11763-123H8	599.06	28.98	3.49	9.77	0.35
tenocyte, donor2	11765-123I1	541.74	17.93	3.43	5.72	1.14
tenocyte, donor3	11768-123I4	589.73	40.40	3.71	10.75	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	2543.29	210.58	3.57	157.38	2.21
teratocarcinoma cell line:NCR-G1	10798-110I6	1115.88	23.58	1.70	29.90	0.15
teratocarcinoma cell line:PA-1	10807-111A6	1571.63	43.86	1.24	85.08	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	1155.98	69.69	1.02	47.48	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	2077.68	60.51	1.51	57.48	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	1730.06	44.61	1.85	43.30	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	2361.35	105.53	17.91	36.15	4.56
testis, adult, pool1	10026-101D8	1139.01	17.61	0.54	14.39	0.43
testis, adult, pool2	10096-102C6	618.44	21.65	2.26	28.87	0.45
thalamus - adult, donor10196	10168-103B6	417.31	12.14	0.00	6.62	0.00
thalamus, adult, donor10252	10154-103A1	604.03	21.72	0.94	4.53	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	160.12	18.48	0.00	12.32	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	275.03	9.39	1.81	4.94	0.00
thalamus, newborn, donor10223	10366-105F6	227.83	13.81	0.00	13.23	0.00
throat, adult	10209-103G2	725.54	17.48	1.00	4.24	1.00
throat, fetal, donor1	10061-101H7	1393.42	10.36	3.35	11.88	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	2161.21	79.89	1.79	30.21	1.19
thymus, adult, pool1	10027-101D9	1720.18	17.89	0.89	7.65	0.10
thymus, fetal, pool1	10043-101F7	1401.88	17.46	0.62	7.79	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	886.72	55.31	1.20	25.40	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	2248.60	50.15	4.75	42.33	1.54
thyroid, adult, pool1	10028-101E1	2443.03	26.50	1.49	5.51	0.47
thyroid, fetal, donor1	10060-101H6	805.23	12.13	2.11	6.86	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	532.77	12.32	0.00	9.24	0.00
tongue, adult	10203-103F5	843.56	36.98	3.49	11.16	2.09
tongue, fetal, donor1	10059-101H5	1060.50	17.73	1.58	9.06	0.39
tonsil, adult, pool1	10047-101G2	1477.59	22.94	0.50	4.81	0.10
trachea, adult, pool1	10029-101E2	1259.45	29.37	0.65	6.71	0.16
trachea, fetal, donor1	10058-101H4	1095.61	14.23	3.08	6.16	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	698.28	47.47	1.42	17.71	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	1580.54	52.38	0.41	18.34	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	3511.99	75.68	2.98	41.37	1.25
tridermal teratoma cell line:HGRT	10694-109G1	283.48	3.81	0.00	7.61	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	1524.98	24.38	2.29	9.31	0.51
umbilical cord, fetal, donor1	10057-101H3	769.92	14.61	2.09	12.52	0.00
uterus, adult, pool1	10100-102D1	1779.48	15.02	0.68	5.46	0.00
uterus, fetal, donor1	10055-101H1	1791.24	9.73	6.66	8.70	2.56
vagina, adult	10204-103F6	1327.29	5.17	1.94	3.23	0.65
vein, adult	10191-103E2	998.01	7.89	3.07	4.16	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	1556.56	29.91	2.94	15.49	2.14